Internet and written sources good for supplementing healthcare professional information [ , , , , , , , , , ].
Support networks provide unique insights for carers [ , , ].
. | . | . |
---|---|---|
Accessing | Pharmacists can be useful in providing information [ ]. Internet and written sources good for supplementing healthcare professional information [ , , , , , , , , , ]. Support networks provide unique insights for carers [ , , ]. | Language difficulties, including too high level and translation requirements [ , ]. Fragmentation and complexity of care resulting in information gaps [ , ]. Transportation difficulties to consultations not allowing carers to receive information [ ]. |
Understanding | Simple, relevant information using practical examples helps understanding [ , , , ]. Healthcare professional taking time to explain the information to both person living with dementia and their carer [ , ]. Dose administration aids including Webster-paks are useful in knowing what and when to give/take medications [ ]. | Written information often complex, long, not appropriate and appears to be targeted to professionals [ , , , ]. When not present at the meeting, carers not given opportunity to understand information fully [ , ]. Information given at transitions of care, when care is fragmented, at the initial diagnosis, and if given all-at-once is difficult to fully understand [ , , , , , , ]. |
Implementing | Brief, one-on-one information for clarity and full understanding [ , , , , ]. Simple written resources, such as checklists [ ]. Medications lists at hospital discharge provide information not otherwise given [ ]. | Information on benefits and risks of medications too generic [ , , ]. Healthcare professionals and other resources not considering potential prior knowledge of people [ ]. Mixing brand and generic names of medications adds confusion [ ] |
Actioning | Unique, personalised strategies developed over time to manage medications [ , , , ]. Question prompts and other ‘empowerment’ tools prompt shared decision-making [ ]. Automatic dispensers and personalised medication records useful [ , , ] | Lack of knowledge impairs decision-making on medications [ , ]. Cold and clinical information, especially received at home, increases anxiety [ , ]. Complex regimes limit effective proper usage [ ] |
People living with dementia and their carers wanted and expected, to access medication management information directly from healthcare professionals stating they placed great trust in them [ 20 , 24 , 30–32 , 35 , 39 , 44 , 48 , 50 ]. However, it was commonly reported that healthcare professionals did not always provide this information, and, if they did, it was insubstantial, lacking relevancy and resulted in recipients having to source their own information [ 20 , 31 , 35 , 38 , 39 , 44 , 54 ]. This mostly came from internet searches [ 31 , 38 , 44 , 54 ] and printed sources [ 44 , 54 ] that may be inaccurate or misleading, such treatment duration varying between online suggestions and prescriber recommendations [ 44 ]. Additional medication management information was accessed from: patient information sheets [ 24 , 44 , 50 ], direct-to-consumer educational brochures [ 33 , 44 ], factsheets from dementia organisations [ 28 , 48 , 54 ], support groups [ 28 , 30 , 32 , 35 , 44 ], family members [ 36 ], other healthcare professionals [ 44 , 47 ], conferences [ 28 , 35 ] and internet-based resources [ 24 , 28 , 30–32 , 35 , 38 , 41 , 44 , 47 , 48 , 54 ].
Many people indicated that written information, while useful, was often difficult to fully understand due to its length and complexity [ 30 , 31 , 40 , 44 ]. Thus, it was appreciated when healthcare professionals took the time to not only explain the information they were giving, but also go through written information otherwise accessed [ 26 , 34 , 43 , 52 ]. This was considered especially important when there were cultural and religious factors that may affect medication use [ 20 , 37 ]. Sometimes, carers had to seek healthcare professionals who spoke their language, even if it delayed care [ 32 ]. Dose administration aids were commonly used but limitations were noted regarding their practicality for use in this population, such as Webster-paks having small font size [ 30 ].
Frustration at the lack of opportunities and resources to fully interpret and evaluate the medication management information received from healthcare professionals was reported as an issue [ 26 , 30 , 31 , 35 , 47 , 54 ]. People living with dementia and their carers suggested a person-to-person approach providing brief, tailored information as the need arises would be more useful and allow for informed choices to be made [ 43 ]. Carers recommended written resources, such as checklists, that could contain key, simple information on medications and assume a certain prior knowledge of the healthcare system [ 40 , 52 ]. Reputable sources, including the Mayo clinic and dementia websites, were considered valuable by those conducting their own searches, and people living with dementia and their carers commonly triangulated the information to satisfy their requirements [ 34 , 35 ].
Confidence and the ability to employ useful medication management strategies such as implementing dosing schedules increased in line with experience but, importantly, it also rose when people living with dementia and their carers were involved in shared decision-making [ 28 , 35 ]. However, when information was not fully given, or carers were not afforded the opportunity to participate in shared decision-making, problems arose [ 40 ]. This sometimes resulted in medication decisions being made without expert advice, such as carers making up their own medications lists, increasing the potential for errors and carer burden [ 40 , 44 ]. Medication reviews were also seen as great facilitators in improving medication management [ 31 , 32 ].
To our knowledge, this is the first review of medication management information needs and priorities of people living with dementia and their carers, involving 35 studies with 378 people living with dementia and 1757 carers. It was reported that more information was required on every aspect of medication management to ensure the safe and appropriate use of medications. The priorities for information need related to critical medical information, the reasons for and effects of medications, impact of dementia progression on the use of medications, and safe and appropriate administration of medications. People living with dementia and their carers wanted clear, concise and relevant information and to be more involved in medication decisions. This review identified that people living with dementia and their carers are provided limited and inadequate information to manage medications.
Healthcare professionals were seen as both significant supporters for people living with dementia and their carers but also imposing barriers for receiving, understanding and putting medication management information into action [ 35 ]. These findings align with other studies, where people living with dementia and their carers expressed dissatisfaction with the communication from healthcare professionals [ 17 , 57 ], perceiving it as disjointed and not meeting their needs [ 13 , 58 ]. Transitions of care were described as particularly challenging periods for managing medications, primarily due to fragmented care and a lack of consideration for the impact of dementia on medication management [ 29 , 44 ]. From a carer perspective, this exacerbates their stress and burden which worsens their health and can subsequently negatively impact the person they are caring for [ 59 ]. Current planning misses these unique challenges and does not address the realities, such as the importance of the carer and managing changed behaviour during goals of care discussions [ 11 ]. Indeed, a previous review of successful care transition interventions for medication continuity among older adults did not describe what impact any level of cognitive impairment would have upon the ‘success’ of care transitions [ 14 ]. Proposed solutions could include incorporating a multidisciplinary team as part of in-hospital care for people living with dementia, such as involving pharmacists and pharmacologists in physician rounds to detect potential medication issues and propose interventions acceptable to patients, carers and prescribers [ 60 , 61 ]. Fundamentally, prioritising person-centred care, involving the person living with dementia and their carer in medication-related decisions while considering their acquired experience and knowledge, and having coordinated, responsive and tailored care can help address medication management challenges [ 11 , 35 , 43 , 52 , 62 ].
Not only is emphasising patient-centred care preferable to people living with dementia and their carers [ 63 , 64 ], but it has also demonstrated improved health outcomes [ 65 ]. Carers specifically highlighted the benefit of one-on-one meetings with a healthcare professional in which information was briefly and simply explained and repeated to ensure full understanding [ 30 , 31 , 37 ]. This verbal communication should be combined with accurate and understandable written information, due to both people living with dementia and their carers’ needs [ 26 , 40 ], and because of the frequent use and reliance of written information [ 58 ]. Developing these materials requires a collaborative approach between people living with dementia, carers, healthcare professionals and researchers that emphasises experience-gathering and co-design at every stage of resource development [ 66 ]. While previous reviews have explored the issues related medication management experienced by people living with dementia and their carers, and examined the available resources to assist this, none identified what the specific needs are [ 13 , 67 ]. This review adds to the evidence by identifying the information needs of people living with dementia and their carers regarding medication management so these can be addressed in any future resource development.
Further work is required to directly confirm the information gaps identified in this review with people living with dementia, carers and healthcare professionals and explore the priorities for medication management information across care settings that have not been captured in this scoping review. The identified priorities can be used as foundations for the development of co-designed medication management tools that address the unique needs of people living with dementia and carers.
This review has several strengths. First, several databases were searched to identify studies reporting medication management information needs of people living with dementia and their carers. Second, data integrity was assured with two authors reviewing and extracting data for each study. Third, reference list checking and citation tracking ensured any studies missed through initial searches were captured.
This review does have one major limitation, however. Although the number of studies reporting each information need was extracted, the ordered priorities and how many people within each study reported the information need was not extracted. This is because not all studies included this data, and although direct participant quotes were extracted, they may not accurately reflect the priority of that need. Further research is required to confirm the information gaps identified in this review and establish the priorities of these needs. Once validated, these information priorities may act as the foundations of co-designed resources and tools providing accurate, targeted and understandable medication management guidance.
This is the first scoping review to explore and identify the medication management information needs of people living with dementia and their carers. We found that increased, tailored, well-communicated information from healthcare professionals is required. Healthcare professionals are recognized as important sources of this information and people living with dementia and their carers clearly expressed a desire to be more involved in decision-making processes. Written resources need to be more comprehensive and understandable to people living with dementia and their carers that directly address their information needs. Future studies should further confirm the identified information needs to develop targeted medication management information resources.
Amanda J Cross has received grant funding or consulting funds from the Medical Research Future Fund, Pharmaceutical Society of Australia and Dementia Australia Research Foundation. All grants and consulting funds were paid to the employing institution.
Alexander J Clough is supported by an Australian Government Research Training Program (RTP) Scholarship.
Mouna J Sawan is supported by the Dementia Centre for Research Collaboration Fellowship.
Amanda J Cross is supported by a National Health and Medical Research Council Emerging Leadership 1 grant (APP2009633).
Clague F , Mercer SW , McLean G et al. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data . Age Ageing 2017 ; 46 : 33 – 9 .
Google Scholar
Delgado J , Jones L , Bradley MC et al. Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes . Age Ageing 2021 ; 50 : 457 – 64 .
Gillespie R , Mullan J , Harrison L . Managing medications: the role of informal caregivers of older adults and people living with dementia . Int J Older People Nurs 2014 ; 23 : 3296 – 308 .
Freedman VA , Patterson SE , Cornman JC et al. A day in the life of caregivers to older adults with and without dementia: comparisons of care time and emotional health . Alzheimers Dement 2022 ; 18 : 1650 – 61 .
Lau ECY , Wojt I , Jeon YH et al. Prevalence and risk factors for drug-related problems in people with dementia living in the community: a systematic review and meta-analysis . J Am Med Dir Assoc 2022 ; 23 : 980 – 91.e10 .
Sakiris MA , Sawan M , Hilmer SN et al. Prevalence of adverse drug events and adverse drug reactions in hospital among older patients with dementia: a systematic review . Br J Clin Pharmacol 2021 ; 87 : 375 – 85 .
Cross AJ , Etherton-Beer CD , Clifford RM et al. Exploring stakeholder roles in medication management for people living with dementia . Res Social Adm Pharm 2021 ; 17 : 707 – 14 .
Gench M , Sawan MJ , Langford A et al. Tools to evaluate medication management for caregivers of people living with dementia: a systematic review . Health Expect 2021 ; 24 : 1570 – 81 .
Martin F , Turner A , Wallace LM et al. Perceived barriers to self-management for people with dementia in the early stages . Dementia 2013 ; 12 : 481 – 93 .
Tonga JB , Eilertsen DE , Solem IKL et al. Effect of self-efficacy on quality of life in people with mild cognitive impairment and mild dementia: the mediating roles of depression and anxiety . Am J Alzheimers Dis Other Demen 2020 ; 35 : 1533317519885264 .
Hirschman KB , Hodgson NA . Evidence-based interventions for transitions in Care for Individuals Living with dementia . Gerontologist 2018 ; 58 : S129 – s40 .
Sawan M , Clough A , Mirzaei A et al. The carer assessment of MedicaTion management GuidanCe for people with dementia at hospital discharge (CATCH) tool: exploratory factor analysis . Alzheimer Dis Assoc Disord 2024 ; 38 : 59 – 64 .
Widjaja GJ , Gnjidic D , Clough AJ et al. Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan . Expert Rev Clin Pharmacol 2023 ; 16 : 195 – 205 .
Tomlinson J , Cheong VL , Fylan B et al. Successful care transitions for older people: a systematic review and meta-analysis of the effects of interventions that support medication continuity . Age Ageing 2020 ; 49 : 558 – 69 .
Chapter 11: Scoping Reviews (2020 version). https://synthesismanual.jbi.global/ (17 March 2023, last accessed).
Tricco AC , Lillie E , Zarin W et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation . Ann Intern Med 2018 ; 169 : 467 – 73 .
Harper AE , Terhorst L , Moscirella M et al. The experiences, priorities, and perceptions of informal caregivers of people with dementia in nursing homes: a scoping review . Dementia 2021 ; 20 : 2746 – 65 .
Informal carers. https://www.aihw.gov.au/reports/australias-welfare/informal-carers (15 December 2023, last accessed).
Sørensen K , Van den Broucke S , Fullam J et al. Health literacy and public health: a systematic review and integration of definitions and models . BMC Public Health 2012 ; 12 : 80 .
Alsaeed D , Orlu M , Smith F . Optimising medication use along dementia progression: recommendations from a qualitative study . Healthcare 2021 ; 9 : 982 .
Armstrong MJ , Gamez N , Alliance S et al. Clinical care and unmet needs of individuals with dementia with Lewy bodies and caregivers: an interview study . Alzheimer Dis Assoc Disord 2021 ; 35 : 327 – 34 .
Badawoud AM , AlQadheeb YK , AlZahrani SS et al. The level of burden among caregivers of patients with Alzheimer's disease in Saudi Arabia . Int J Env Res Pub He 2023 ; 20 : 2864 .
Bardach SH , Gibson A , Parsons K et al. Rural caregivers: identification of informational needs through telemedicine questions . J Rural Health 2021 ; 37 : 406 – 11 .
Barry HE , McGrattan M , Ryan C et al. I just take them because I know the people that give them to me': a theory-informed interview study of community-dwelling people with dementia and carers' perspectives of medicines management . Int J Geriat Psychiatry 2021 ; 36 : 883 – 91 .
Behrman S , Wilkinson P , Lloyd H et al. Patient safety in community dementia services: what can we learn from the experiences of caregivers and healthcare professionals? Age Ageing 2017 ; 46 : 518 – 21 .
Bloomstone S , Anzuoni K , Cocoros N et al. Prescribing cascades in persons with Alzheimer’s disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials . Drug Saf 2020 ; 11 : 204209862096831 .
Cornege-Blokland E , Kleijer BC , Hertogh C et al. Reasons to prescribe antipsychotics for the Behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians . J Am Med Dir Assoc 2012 ; 13 : 80.e1 – 6 .
De Bellis A , Bradley SL . Antipsychotic use for behaviours by persons with dementia in residential aged care: the relatives' perspectives . Aust J Adv Nurs 2017 ; 35 : 23 – 32 .
Deeks LS , Cooper GM , Draper B et al. Dementia, medication and transitions of care . Res Social Adm Pharm 2016 ; 12 : 450 – 60 .
El-Saifi N , Moyle W , Jones C . Family caregivers' perspectives on medication adherence challenges in older people with dementia: a qualitative study . Aging Ment Health 2019 ; 23 : 1333 – 9 .
El-Saifi NNF , Moyle W , Jones CJ et al. The perceptions of informal carers of older people with dementia about the role of their pharmacists . Int J Pharm Pract 2021 ; 29 : 465 – 70 .
Gillespie RJ , Harrison L , Mullan J . Medication management concerns of ethnic minority family caregivers of people living with dementia . Dementia 2015 ; 14 : 47 – 62 .
Green AR , Boyd CM , Gleason KS et al. Designing a primary care-based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study . J Gen Intern Med 2020 ; 35 : 3556 – 63 .
Horne F , Burns P , Traynor V et al. Managing medications for individuals living with a dementia: evaluating a web-based information resource for informal carers . Int J Older People Nurs 2018 ; 13 : e12198.
Kimzey M , Howe CJ , Martin C et al. Development of health literacy in persons and caregivers living with dementia: a qualitative directed content analysis . Dementia 2022 ; 21 : 540 – 55 .
Lynnerup C , Rossing C , Sodemann M et al. Perspectives on medication safety from vulnerable older migrants and their relatives-a qualitative explorative study . Basic Clin Pharmacol Toxicol 2023 ; 132 : 392 – 402 .
Maidment ID , Aston L , Moutela T et al. A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist . Health Expect 2017 ; 20 : 929 – 42 .
Martínez-Lage P , Pepp M . Alzheimer's disease and its treatment with a novel transdermal patch therapy: survey of caregiver experiences . Prim Care Companion CNS Disord 2012 ; 14 : 26617 .
McCloskey B , Hughes C , Parsons C . A qualitative exploration of proxy decision makers' expectations of prescribed medications for people with advanced dementia . Palliative Med 2018 ; 32 : 1114 – 23 .
Poland F , Mapes S , Pinnock H et al. Perspectives of carers on medication management in dementia: lessons from collaboratively developing a research proposal . BMC Res Notes 2014 ; 7 : 463 .
Rathnayake S , Moyle W , Jones C et al. Family carers' needs related to management of functional disability in dementia care and use of mHealth applications in health information seeking: an online survey . Collegian 2020 ; 27 : 288 – 97 .
Rees JL , Burton A , Walters KR et al. Exploring how people with dementia can be best supported to manage long-term conditions: a qualitative study of stakeholder perspectives . BMJ Open 2020 ; 10 : e041873.
Reeve E , Chenoweth L , Sawan M et al. Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questions . J Alzheimers Dis 2023 ; 91 : 933 – 60 .
Sawan MJ , Jeon YH , Bond C et al. Caregivers' experiences of medication management advice for people living with dementia at discharge . J Eval Clin Pract 2021 ; 27 : 1252 – 61 .
Seike A , Sumigaki C , Takeda A et al. Developing an interdisciplinary program of educational support for early-stage dementia patients and their family members: an investigation based on learning needs and attitude changes . Geriatr Gerontol Int 2014 ; 14 : 28 – 34 .
Shariff Z , Kirby D , Missaghi S et al. Patient-centric medicine design: key characteristics of Oral solid dosage forms that improve adherence and acceptance in older people . Pharmaceutics 2020 ; 12 : 905 .
Smith F , Grijseels MS , Ryan P et al. Assisting people with dementia with their medicines: experiences of family carers . Int J Pharm Pract 2015 ; 23 : 44 – 51 .
Wald C , Fahy M , Walker Z et al. What to tell dementia caregivers--the rule of threes . Int J Geriatr Psych 2003 ; 18 : 313 – 7 .
Wherton JP , Monk AF . Technological opportunities for supporting people with dementia who are living at home . Int J Human-Computer Studies 2008 ; 66 : 571 – 86 .
While C , Duane F , Beanland C et al. Medication management: the perspectives of people with dementia and family carers . Dementia 2013 ; 12 : 734 – 50 .
Wolfs CA , de Vugt ME , Verkaaik M et al. Empowered or overpowered? Service use, needs, wants and demands in elderly patients with cognitive impairments . Int J Geriatr Psych 2010 ; 25 : 1006 – 12 .
Wolverson E , Harrison Dening K , Gower Z et al. What are the information needs of people with dementia and their family caregivers when they are admitted to a mental health ward and do current ward patient information leaflets meet their needs? Health Expect 2023 ; 26 : 1227 – 35 .
Yeh JC , Newman J , Main R et al. Improving end-of-life Care for Persons Living with dementia: bereaved Caregivers' observations and recommendations . J Pain Symptom Manage 2021 ; 62 : 579 – 86 .
Zubatsky M , Aragon-Prada M , Muse F et al. Navigating without a roadmap: challenges of early Alzheimer's caregivers with their health care team. Glob qual . Nurs Res 2016 ; 3 : 2333393616673465 .
Tabulated display of CHI. https://www.tga.gov.au/resources/resource/guidance/medicine-labels-guidance-tgo-91-and-tgo-92/4-tabulated-display-chi (30 January 2024, last accessed).
Medication Safety Standard. https://www.safetyandquality.gov.au/standards/nsqhs-standards/medication-safety-standard (30 January 2024, last accessed).
Khanassov V , Rojas-Rozo L , Sourial R et al. Needs of patients with dementia and their caregivers in primary care: lessons learned from the Alzheimer plan of Quebec . BMC Fam Pract 2021 ; 22 : 186 .
Soong A , Au ST , Kyaw BM et al. Information needs and information seeking behaviour of people with dementia and their non-professional caregivers: a scoping review . BMC Geriatr 2020 ; 20 : 61 .
Laparidou D , Middlemass J , Karran T et al. Caregivers' interactions with health care services—mediator of stress or added strain? Experiences and perceptions of informal caregivers of people with dementia—a qualitative study . Dementia 2019 ; 18 : 2526 – 42 .
Galvin JE , Valois L , Zweig Y . Collaborative transdisciplinary team approach for dementia care . Neurodegener Dis Manag 2014 ; 4 : 455 – 69 .
Guignard B , Bonnabry P , Perrier A et al. Drug-related problems identification in general internal medicine: the impact and role of the clinical pharmacist and pharmacologist . Eur J Intern Med 2015 ; 26 : 399 – 406 .
Sawan MJ , Wennekers D , Sakiris M et al. Interventions at hospital discharge to guide caregivers in medication Management for People Living with dementia: a systematic review . J Gen Intern Med 2021 ; 36 : 1371 – 9 .
Dooley J , Bass N , Livingston G et al. Involving patients with dementia in decisions to initiate treatment: effect on patient acceptance, satisfaction and medication prescription . Br J Psychiatry 2019 ; 214 : 213 – 7 .
Goossens B , Sevenants A , Declercq A et al. Shared decision-making in advance care planning for persons with dementia in nursing homes: a cross-sectional study . BMC Geriatr 2020 ; 20 : 381 .
Weiner SJ , Schwartz A , Sharma G et al. Patient-centered decision making and health care outcomes: an observational study . Ann Intern Med 2013 ; 158 : 573 – 9 .
Fylan B , Tomlinson J , Raynor DK et al. Using experience-based co-design with patients, carers and healthcare professionals to develop theory-based interventions for safer medicines use . Res Social Adm Pharm 2021 ; 17 : 2127 – 35 .
Lim RH , Sharmeen T . Medicines management issues in dementia and coping strategies used by people living with dementia and family carers: a systematic review . Int J Geriat Psychiatry 2018 ; 33 : 1562 – 81 .
Month: | Total Views: |
---|---|
September 2024 | 249 |
Citing articles via.
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide
Sign In or Create an Account
This PDF is available to Subscribers Only
For full access to this pdf, sign in to an existing account, or purchase an annual subscription.
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Nature Medicine volume 29 , page 279 ( 2023 ) Cite this article
6875 Accesses
7 Citations
24 Altmetric
Metrics details
The international community needs to prioritize research on interventions and preventative measures for dementia that are likely to produce the greatest global impact.
Dementia is the seventh leading cause of death worldwide, and the number of people living with this disorder is expected to triple by 2050 . The burden of dementia is not equal across all countries, with around two thirds of people with dementia living in low- and middle-income countries (LMICs), where increases are predicted to occur more rapidly than in higher-income countries (HICs). Women are disproportionately affected by dementia, with greater prevalence rates than men in all age groups and a higher proportion of deaths. Women are also responsible for providing roughly 70% of informal care hours globally, with the highest proportions being in LMICs.
Although progress has been made, research into dementia remains fragmented and siloed to areas unlikely to generate the greatest global impact. Even the recent approval of lecanemab by the US Food and Drug Administration is tempered by the fact that the cost and infrastructure requirements of this treatment are likely to be prohibitive for LMICs — where most people with dementia reside. The World Health Organization (WHO) global status report on the public health response to dementia in 2017–2025 highlights the need for increased efforts globally to reach the dementia targets set for 2025 by Member States. The report’s bottom line is unequivocal: it is time for the international community to prioritize research on interventions and preventative measures that are likely to benefit all people at risk of dementia.
On 4 October 2022, the WHO released a dementia research blueprint to support implementation of the Global action plan on the public health response to dementia in 2017–2025, representing a first-of-its-kind publication in the context of non-infectious diseases. Leveraging key lessons learned from previous WHO efforts to prioritize and coordinate research into infectious diseases, the blueprint emphasizes key objectives across the entire dementia research spectrum that will have the greatest impact on the global burden of this devastating disorder. For example, a better understanding of the prevalence and incidence of dementia, the costs of illness and the prevalence and impact of risk factors is needed in LMICs and other ethnic and regional groups. Research into the mechanisms of dementia, such as biomarkers and genetic and epigenetic markers, should include and account for differences in these groups. This may require improved engagement and collaboration with communities that may be less willing or unable to participate in these types of studies.
Studies in HICs have reported a decrease in the prevalence of dementia, linked to modifiable dementia risk factors. These exciting findings suggest that modification of risk factors could slow cognitive decline and delay the onset of dementia, or prevent it altogether. Given the costs of dementia care, primary prevention is likely to be the cheapest and easiest way to reduce the projected global impact of dementia. Yet there are little data available on modifiable risk factors in LMICs or in culturally, ethnically and sexually diverse sub-populations in both HICs and LMICs. Furthermore, the data used to calculate these risk factors are from HICs, despite studies showing that some risk factors are more prevalent than others in LMICs and account for more cases of dementia there than in the rest of the world . Differing environmental and social exposures also influence dementia risk. This includes exposure to air pollution and pesticides, which is associated with an increased dementia risk, whereas proximity to green spaces is linked to positive cognitive outcomes.
There are also few robust studies on sex-specific risk factors such as early menopause and complications during pregnancy and on the differential effect of risk factors in men and women, as recently shown for cardiovascular events. It is now generally accepted that longevity alone is not responsible for sex differences seen in dementia, and studies are increasingly highlighting a biological component. Men and women with Alzheimer’s disease (AD) exhibit different cognitive and psychiatric symptoms, and women show faster cognitive decline after a diagnosis of mild cognitive impairment or AD dementia. Epidemiological studies demonstrate that the allele encoding apolipoprotein E confers different AD risk profiles on the basis of sex, with women who have the allele encoding apolipoprotein E-ε4 being at greater risk for developing AD than age-matched men are. Despite these findings, little to no data are available on sex differences in the efficacy and safety of drugs used in recently completed phase 3 clinical trials for mild to moderate AD. Furthermore, women remain under-represented in clinical trials for AD . Systematic studying and reporting of sex differences in disease symptomatology, biomarkers, progression, risk factors and treatment responses will be crucial for efforts to reduce the global impact of dementia.
Funding is obviously the key driver of research. Data for 2019 indicate that although funding for dementia has increased, it is directed mainly toward research in HICs. Of the 50 organizations and institutions that received the most grants for dementia research in 2019, 41 were in the United States, 6 were in the United Kingdom and 3 were in Canada. Furthermore, the vast majority of funding is directed toward research into AD, despite the fact that dementia is caused by several diseases. Although increased funding for dementia research is a step in the right direction, this needs to happen in a more structured and equitable fashion.
Dementia is highly complex, and the challenge of tackling the global burden of this disorder cannot be overcome by people working in silos. Considerable research gaps exist in the understanding of this disorder, particularly in areas in which its burden is greatest. Closing these gaps requires implementation of a harmonized global research plan with equitable inclusion and research capacity-building in under-resourced settings. Only such a level of global research prioritization can ensure that ongoing research efforts deliver the greatest impact possible.
Reprints and permissions
Cite this article.
Dementia research needs a global approach. Nat Med 29 , 279 (2023). https://doi.org/10.1038/s41591-023-02249-z
Download citation
Published : 15 February 2023
Issue Date : February 2023
DOI : https://doi.org/10.1038/s41591-023-02249-z
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing.
Nature Medicine (2024)
In global approaches to dementia research, do not forget care.
Nature Medicine (2023)
Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.
A .gov website belongs to an official government organization in the United States.
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
Related Topics:
The conditions in which people are born, grow, work, live, and age are known as social determinants of health (SDOH). They are the underlying social, economic, policy, and other nonmedical factors that influence health.
These conditions can:
More work needs to be done to determine the exact relationship between these factors and dementia. But there is growing research around the social and economic factors that contribute to a person's health status, including their risk for dementia. These factors, as well as public health solutions to address disparities in ADRD, are explored below.
Alzheimer's disease is the most common form of dementia. 1
A recent study suggests that the number of people with clinical Alzheimer's disease is expected to increase from about 6.9 million people in 2024 to about 14 million people in 2060. 1
There are a number of factors that may account for the increased risk of Alzheimer's disease among these groups, when compared to White populations:
Significantly more women than men have Alzheimer's disease. 1 This is primarily because women typically live longer than men.
The disparity between women and men is expected to widen in the coming decades.
Between 2020 and 2060:
Unequal access to quality care.
Experiences in ADRD care and support services can be different depending on race, ethnicity, geography, and social and economic factors.
For example, factors in health care settings that can contribute to disparities in ADRD care include:
Community factors that can contribute to health care disparities in some racial and ethnic groups include:
Caregivers are an important part of the care and support team for people with ADRD. Yet an Alzheimer's Association report of caregivers from racial and ethnic minority groups showed that: 2
These disparities go beyond the medical care provided to patients with ADRD and their caregivers. They include unequal representation of Black, Hispanic, Asian, and American Indian or Alaska Native persons in clinical trials for Alzheimer's disease.
Public health response.
Understanding the disparities in ADRD is the first step toward developing and implementing strategies and services for those most at risk for developing the disease.
There is still much work to be done to address health and health care disparities in ADRD care 3 . Public health agencies can address this problem by helping:
Dementia is not a specific disease. It is a general term for having trouble remembering, thinking, or making decisions that affect everyday activities.
Public health.
William McEwan, Ph.D., spent years unraveling how an antiviral protein, tripartite motif-containing 21 (TRIM21), protects our cells from infection. Working in the lab of Leo James, Ph.D., McEwan and collaborators realized that TRIM21 marks viruses to be destroyed by the cell’s waste disposal system —but only activates when enough of the proteins cluster together.
McEwan and James have now taken advantage of TRIM21’s cluster activation by turning it against another protein with a penchant for aggregation: the misfolded tau protein that causes Alzheimer’s and other neurodegenerative diseases. In two new papers, they demonstrate how two TRIM21-based techniques can remove tau tangles inside of mouse neurons while leaving healthy tau alone and improve mobility in a mouse model of Alzheimer’s disease.
“These two articles by the groups of William McEwan and Leo James are very interesting,” Einar Sigurdsson, Ph.D., a neuroscientist at NYU Grossman School of Medicine, and colleagues wrote in a forthcoming commentary that Sigurdsson shared in advance with Fierce Biotech. “Both of these potential therapies are successful in clearing pathological tau.”
Our cells normally use TRIM21 as a last line of defense against viruses that manage to breach the cell membrane. Once McEwan, now at the UK Dementia Research Institute at the University of Cambridge, understood how TRIM21 is activated by bunching together, he saw its potential to go after tau aggregates right away.
“It's only when it's forced to cluster on the surface of a virus that it becomes activated,” McEwan told Fierce in an interview. “We asked whether this could therefore allow us to encode specificity for aggregates.” In a 2017 study, he found that TRIM21, combined with antibodies that target tau, could effectively destroy tangles of misfolded tau protein in human cells.
To turn TRIM21 into a treatment, McEwan and James, of the Medical Research Council Laboratory of Molecular Biology in Cambridge, needed to make the molecule smaller and simpler. They first isolated the part of the protein that does the antiviral dirty work, called the RING domain, and then linked it to two different tau-targeting molecules: a miniature antibody (nanobody) called F8-2 and tau protein itself.
The team engineered genes to code for the RING constructs and delivered them to mice using an adenovirus vector, commonly used in gene therapy. Injecting the RING-nanobody gene into mice with pathogenic tau, either directly into their brains or in their tails (depending on the vector), successfully cleared the aggregated proteins from their brains while not decreasing overall tau levels. The results were published in Science on Aug. 29.
In the other study, the team used tau protein itself as bait, because the misfolded tau seen in Alzheimer’s stick together and turn healthy tau pathological. This RING-Bait gene therapy also cleared tau tangles in mouse brains, and treated mice were able to walk more quickly and with more coordination. These results appeared in Cell on Sept. 13.
“It would have been interesting to see how [the two techniques] compare under identical conditions,” Sigurdsson and colleagues said in their commentary. “The antibody approach would seem to be safer because of better specificity and the RING-domain could possibly be cleaved to some extent from the mutant tau, which could then become pathological.”
“It's a hypothetical possibility” that the tau bait could separate from RING, McEwan said. “We didn't see evidence of that in our study, but it's definitely something you would want to keep an eye out for.”
Recent years have seen a boom in therapies that go after tau, which is a tougher target than the other main neurodegenerative protein—amyloid beta—because it mostly sits inside of brain cells rather than outside of them. Sigurdsson recently published a paper on a gene therapy that produces tau-targeting antibodies , and, in July, AC Immune presented preclinical data on a new class of antibody-drug conjugates that the biotech thinks has “landmark” potential.
McEwan said he’s looking to set up a company to develop other TRIM21-based degrader molecules. He also plans to continue using the new RING techniques to study the basic biology of tau in neurodegenerative disease.
“What really pays is the molecular understanding of the pathogenesis of the disease and the molecular pathways that could be applied to treat it,” McEwan said. “The investment that charities and governmental bodies have put into basic research is beginning to come to fruition.”
Academic journals need better ways to detect and deal with fraud, bioinformatics professor sam payne says..
The academic theft was so shameless that Brigham Young University biology professor Sam Payne couldn’t process what he saw on his computer screen.
The academic journal BioSystems had asked Payne to provide a peer review of a paper relevant to his own bioinformatics research, but the moment Payne began to read it he realized the paper wasn’t just related to his work, he believed it literally was his work. Some of the data tables were identical to his own.
“I was so surprised that I had to double check that it was really what I had thought,” he told the Deseret News. “When I read the paper, I first went to talk to my graduate student Hannah Boekweg, who was the lead author of the paper being plagiarized. Even when I described it to her, I was worried that I was somehow mistaken.
“It was so brazen, so clearly plagiarized. I just needed secondary confirmation that this was really happening.”
Payne alerted BioSystems, which rejected the paper in March. But in July, Payne found a reworked version of his and Boekweg’s paper had been published in the journal Proteomics under the names of five other researchers.
This version was more sinister; it was Payne’s and Boekweg’s paper, but it used the third person. Payne believes it was run through an artificial intelligence filter to foil plagiarism checkers.
“I immediately recognized that this was a con and it would be really damaging to science more than it would be to me personally,” Payne said. “My first real reaction was trying to figure out who to contact to get this retracted. Luckily I was able to get in touch with the editor of Proteomics and notify them about the situation.”
A BYU colleague put him in touch with the journal’s parent company, Wiley Publishing.
“Being able to talk to Wiley and their Research Integrity Unit really helped me not be too worried/scared/upset,” Payne said in an email. “I understood their process and was trusting that it would get resolved. If I had been alone in this, it would have been a much different story. But I did not feel helpless. I would say that I was very fortunate and am grateful for my colleagues who helped me find the connections.”
A Wiley spokesperson told Nature magazine , “This paper was simultaneously submitted to multiple journals and included plagiarized images,” adding that, “Our investigation confirmed that systematic manipulation of the publication process was at play.”
So, who stole Payne’s and Boekweg’s work?
The short answer is we may never know, but the hunt for the academic thieves highlighted a major problem in academic publishing.
Proteomics retracted the paper and published a statement that said it had contacted four of the five authors, who said they “did not participate in the writing and submission of the article and gave no consent for publication.” The fifth didn’t respond.
“I don’t know any of the authors, and the situation is still not totally clear as to what actually happened,” Payne told the Deseret News. “In the retraction, several authors say that they were unaware of this paper — including the person listed as the contact author. This is a rather confusing scenario. So it’s not clear to me that we really know what happened.”
Nature magazine published an article about Payne’s plight and its own investigation into what happened. Nature said its news team found links between several of the listed authors and a company called International Publisher, an academic paper mill in Moscow.
International Publisher’s website advertises a selection of more than 10,000 manuscripts, Nature reported, and researchers can pay $500 to $3,000 to be listed as one of the authors of a reworked paper.
Brian Perron, a professor of social work at the University of Michigan who also works as what Nature called a misconduct sleuth, told the magazine that the allegedly plagiarized papers carried several signs of paper-mill articles, including that fact they were submitted to Biosystems and Proteomics in close proximity. (Nature has reported about these hallmarks in the past .)
Payne had previously had a student work on methods to detect fraud and once gave a talk himself about detecting data manipulation, but AI text re-phrasing was new to him.
Payne said that as disconcerting as it was for him and Boekweg, the incident provided an opportunity for academics to consider reform.
He praised Biosystems for quickly rejecting the paper when he discovered the fraud, but he was certain it would be submitted to other journals and tried to learn whether the academic journal had a way to warn other journals that a fraudulent paper existed.
“First, we need a better way to detect fraud” he said. “Because this is a re-phrase of text, it evades plagiarism checkers. We need a much better method for finding fraud.
“Second, we need a better way to deal with fraud. Our current system is not able to handle many scenarios. I’m not an expert here, but hope that publishers take a serious look at their stewardship.
“Third, we need to address the root of the problem. Ultimately this is not a problem of technology, but a problem of integrity.”
Payne said the situation reminded him of a statement made by the President Spencer W. Kimball of The Church of Jesus Christ of Latter-day Saints. In 1975, he gave what is called “ The Second Century Address ” for the centennial of BYU.
“Much misery results from flaws in character, not from failures in technology,” President Kimball said.
“Education needs to include teaching integrity,” Payne said. “This is one area where BYU has an advantage, (with) our dual heritage and ... consistent emphasis to fulfill both an academic and religious mission.”
The original paper by Payne, Boekweg and three others was published in 2021 in Molecular and Cellular Proteomics.
“As single cell proteomics is a new field, we created a method for this simulation and demonstrated how to appropriately design an experiment,” Payne said.
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The PMC website is updating on October 15, 2024. Learn More or Try it out now .
Alessandro pappadà.
1 Department of Psychology, University of Bologna, Bologna, Italy
Ilaria chirico, marco valente, giovanni ottoboni.
2 “G. Prodi” Interdipartimental Center for Cancer Research, Bologna, Italy
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s.
Objectives: Technology can assist and support both people with dementia (PWD) and caregivers. Recently, technology has begun to embed remote components. Timely with respect to the pandemic, the present work reviews the most recent literature on technology in dementia contexts together with the newest studies about technological support published until October 2020. The final aim is to provide a synthesis of the timeliest evidence upon which clinical and non-clinical decision-makers can rely to make choices about technology in the case of further pandemic waves.
Methods: A review of reviews was performed alongside a review of the studies run during the first pandemic wave. PsycInfo, CINAHL, and PubMed-online were the databases inspected for relevant papers published from January 2010.
Results: The search identified 420 articles, 30 of which were reviews and nine of which were new studies meeting the inclusion criteria. Studies were first sorted according to the target population, then summarized thematically in a narrative synthesis. The studies targeting technologies for PWD were categorized as follows: monitoring and security purposes, sustaining daily life, and therapeutic interventions. Each category showed potential benefits. Differently, the interventions for caregivers were classified as informative, psycho-education programs, psychosocial-supportive, therapeutic, and cognitive/physical training. Benefits to mental health, skills learning, and social aspects emerged.
Conclusions: The evidence shows that technology is well-accepted and can support PWD and caregivers to bypass physical and environmental problems both during regular times and during future pandemic waves. Nevertheless, the lack of a common methodological background is revealed by this analysis. Further and more standardized research is necessary to improve the implementation of technologies in everyday life while respecting the necessary personalization.
According to recent statistics, a demographic revolution is currently underway: the average life expectancy is rising worldwide, and the population of persons aged over 60 is going to continually grow until 2050 (United Nations, Department of Economic and Social Affairs, and Population Division, 2020 ; WHO | Global Action Plan on the Public Health Response to Dementia 2017–2025, 2020 ). Even though aging is part of human development, one of the main risks associated with it concerns dementia: 5% of the world population aged over 65 is affected by some types of dementia, and this prevalence doubles around every 5 years (Corrada et al., 2010 ).
Recently, assistive technologies (ATs) have become one of the fundamental pillars of health strategies. They include “ any product or technology-based service that enables people of all ages with activity limitations in their daily life, education, work or leisure ” (Association for the Advancement of Assistive Technology in Europe [WorldCat Identities], 2018 ). Regarding dementia, ATs can increase motor autonomy and reduce the risks associated with wandering thanks to their GPS technology (Liu et al., 2017 ); they can also sustain people's cognitive abilities—those required to accomplish necessary daily activities (Nishiura et al., 2019 ). Again, ATs play a role in supporting the policies surrounding aging in place . Indeed, they can delay people's institutionalization or reduce the number of severe clinical cases requiring admission to care homes (Brittain et al., 2010 ). Besides, technology is useful when admission into a care facility becomes mandatory or is the person's preferred option. In these cases, ATs allow for easier communication between residents and relatives and overcome social barriers (Winstead et al., 2013 ).
Furthermore, ATs increase people's safety by sustaining independence while respecting dignity (Brittain et al., 2010 ). Finally, ATs are associated with benefits when conveying rehabilitation and psychosocial interventions (Peek et al., 2014 ). Technological devices are cheap and affordable (Al-Oraibi et al., 2012 ). Intuitive interfaces support the users' sense of control by highlighting cause–effect relations between tasks and actions (Leng et al., 2014 ). Thanks to personalized items and control processes focused on responding to specific needs and preserving abilities, they increase users' participation in interventions (Smith and Mountain, 2012 ; Darcy et al., 2017 ). Finally, technology promotes remote support and assistance by overcoming environmental barriers (Azad et al., 2012 ).
On the other hand, ATs often present a few limitations. Devices might be experienced as intrusive and invading the users' privacy (Dorsten et al., 2009 ). Again, they can be obstructive and increase the stigma that sometimes comes with the disease (Pritchard and Brittain, 2015 ). Moreover, complicated features, or intense learning sessions, might underline cognitive abilities loss, leading to frustration and rejection of technology (Peek et al., 2014 ).
Recently, the remote feature has begun to characterize ATs more and more, as it becomes useful to bridge the distance between people (Cuffaro et al., 2020 ). Capitalizing on the positive evidence about AT and dementia (Meiland et al., 2017 ), it may be conceivable to assume that ATs might play a key role in the attempts to alleviate the future burden lockdowns might bring with them (INDUCT, 2020 ). At the same time, to keep people safe, technological devices might support people with dementia and caregivers during the months of lockdown (Meiland et al., 2020 ).
Timely with respect to the pandemic, the present work reviews the most recent literature reviews on ATs in dementia contexts together with a review of the new studies adopting ATs during the virus outbreak.
The current work's final aim is to provide a tangible summary upon which clinical and non-clinical decision-makers can base their choices about which technological intervention tools they can deploy to directly compensate/improve specific dysfunctionalities affecting either people with dementia or caregivers even during future pandemic waves.
PsycINFO, PubMed, and CINAHL were the online databases where we sought peer-reviewed papers published from January 2010 to October 2020 ( Table 1 ). The research query combined keywords from three different research strings (A, B, C) through the Boolean operators “AND” and “OR” ( Table 2 ). String A included the studies that were related to technology in general. Due to the lack of standardized terminology (Roest et al., 2017 ), several terms were derived from the APA thesaurus. String B selected the target population. String C filtered for the methodology of interest.
Initial search data.
A | 49,933 | 66,372 | 147,950 |
A AND B | 354 | 592 | 1,082 |
A AND B AND C | 109 | 111 | 197 |
Complete query used.
(KW (technology or technologies) OR KW telemedicine OR KW assistive device OR KW App OR KW computer OR KW tablet OR KW telecommunication OR KW web-based OR KW online OR KW internet OR KW (telecare or “tele care”) OR KW (ehealth or e-health or electronic health) OR KW (telehealth or “tele health”) OR KW digital OR KW (videotelephone or “video phone”) OR KW video chat OR KW video communication)) AND (KW (dementia or alzheimer)) AND (TI intervention OR KW intervention OR AB intervention) | ((((technology[Other Term] OR technologies[Other Term] OR telemedicine[Other Term] OR assistive device[Other Term] OR App[Other Term] OR computer[Other Term] OR tablet[Other Term] OR telecommunication[Other Term] OR web-based[Other Term] OR online[Other Term] OR internet[Other Term] OR telecare[Other Term] OR tele care[Other Term] OR ehealth[Other Term] OR e-health[Other Term] OR electronic health[Other Term] OR telehealth[Other Term] OR tele health[Other Term] OR digital[Other Term] OR videotelephone[Other Term] OR video phone[Other Term] OR video chat[Other Term] OR video communication[Other Term])) AND (dementia[Other Term] OR alzheimer[Other Term]))) AND ((intervention[Title/Abstract]) OR intervention[Other Term]) | ((SU (technology or technologies) OR SU telemedicine OR SU assistive device OR SU App OR SU computer OR SU tablet OR SU telecommunication OR SU web-based OR SU online OR SU internet OR SU (telecare or “tele care”) OR SU (ehealth or e-health or electronic health) OR SU (telehealth or “tele health”) OR SU digital OR SU (videotelephone or “video phone”) OR SU video chat OR SU video communication)) AND SU (dementia or alzheimer))) AND (TI intervention OR SU intervention OR AB intervention) |
To summarize the most recent literature related to the use of technology, the present review combines the review of reviews methodology (Smith et al., 2011 ) with a literature review including the most recent studies on the topic that are still not reviewed.
The included studies are those that are as follows: peer-reviewed, published from January 2010 to October 2020, available in English or Italian, and those that deal with any technological devices. The studies analyze interventions on both people diagnosed with dementia and their caregivers. Moreover, we ascertain any method: experimental, quasi-experimental, or single-case studies.
We excluded studies if the target population was composed of MCI or the authors did not explicitly sort the results between PWD and MCI. Moreover, we do not accept any papers reporting only dementia technological assessments or diagnoses.
The selection process is showed in the PRISMA flow diagram in Figure 1 . The search brought out 420 papers, 123 of which were removed because of duplicates. Both the title and the abstract of the 297 remaining documents were checked. Ninety-two documents emerged from this former analysis, of which 39 were review papers, and 53 were new studies. Nine reviews were further excluded. Once they were fully read, they did not meet the eligibility criteria: three were excluded for the target population, four were excluded because devices were aimed only at diagnosing, and two were excluded for the methodology.
Revision flow chart.
Out of the 53 new studies, 41 were already in the reviews, and three of them did not meet the inclusion criteria: two of them due to the target population and one for the methodology (i.e., protocol report). In the end, 30 reviews and nine new studies were included in the present work and thoroughly analyzed.
At first, we assessed the quality of the included systematic reviews through either the AMSTAR tool guidance for the systematic reviews (Shea et al., 2009 ) or the SANRA scale for the non-systematic reviews (Baethge et al., 2019 ; Tables 3 , ,4, 4 , respectively). A formal assessment of the new studies was not performed, as it was urgent to update the pandemic-related literature, despite the study quality.
Quality assessment of systematic reviews using AMSTAR.
Boots et al. ( ) | Y | CA | Y | N | N | Y | Y | Y | NA | N | Y | 6 |
Brims and Oliver ( ) | Y | N | Y | Y | N | Y | N | Y | Y | Y | Y | 8 |
Daly Lynn et al. ( ) | Y | Y | Y | Y | N | Y | N | Y | NA | N | Y | 7 |
Dam et al. ( ) | Y | Y | Y | Y | N | Y | Y | Y | NA | Y | Y | 9 |
Egan et al. ( ) | Y | Y | Y | N | N | Y | Y | Y | NA | Y | Y | 8 |
El-Saifi et al. ( ) | Y | Y | Y | Y | N | Y | N | N | NA | N | Y | 6 |
Fleming and Sum ( ) | Y | CA | Y | N | N | Y | Y | Y | NA | N | N | 5 |
García-Casal et al. ( ) | Y | CA | Y | N | N | Y | Y | Y | Y | N | Y | 7 |
Godwin et al. ( ) | Y | N | Y | Y | N | Y | N | Y | NA | N | Y | 6 |
Hopwood et al. ( ) | Y | Y | Y | Y | N | N | Y | Y | NA | Y | Y | 8 |
Jackson et al. ( ) | Y | Y | Y | Y | N | Y | Y | Y | NA | Y | Y | 9 |
Lazar et al. ( ) | Y | Y | Y | Y | N | Y | N | Y | NA | N | Y | 7 |
Leng et al. ( ) | Y | Y | Y | N | N | Y | Y | Y | Y | Y | Y | 9 |
Liapis and Harding ( ) | Y | CA | Y | Y | N | Y | Y | Y | NA | N | Y | 7 |
Lucero et al. ( ) | Y | Y | Y | N | N | Y | Y | Y | NA | Y | Y | 8 |
Maia et al. ( ) | Y | Y | Y | Y | N | Y | Y | Y | NA | Y | Y | 9 |
McKechnie et al. ( ) | Y | CA | Y | Y | N | Y | Y | Y | NA | N | Y | 7 |
Parra-Vidales et al. ( ) | Y | Y | Y | N | N | Y | N | Y | NA | N | N | 5 |
Pinto-Bruno et al. ( ) | Y | Y | Y | N | N | Y | Y | Y | NA | N | Y | 7 |
Ruggiano et al. ( ) | Y | Y | Y | Y | N | Y | Y | Y | NA | N | Y | 8 |
Scott et al. ( ) | Y | Y | Y | N | N | Y | Y | Y | Y | Y | Y | 9 |
Tyack and Camic ( ) | Y | Y | Y | Y | N | Y | Y | Y | NA | N | Y | 8 |
Waller et al. ( ) | Y | Y | Y | Y | N | Y | Y | Y | NA | Y | Y | 9 |
23 | 16 | 23 | 14 | 0 | 22 | 17 | 22 | 4 | 10 | 21 |
Scores: CA, can't answer; N, no; NA, not applicable; Y, yes (Shea et al., 2009 ) .
Quality assessment of non-systematic reviews using SANRA.
Brando et al. ( ) | 2 | 2 | 2 | 2 | 2 | 1 | 11 |
Dove and Astell ( ) | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
Klimova and Maresova ( ) | 2 | 2 | 2 | 2 | 1 | 1 | 10 |
Lorenz et al. ( ) | 1 | 2 | 1 | 2 | 2 | 2 | 10 |
Neubauer et al. ( ) | 2 | 2 | 2 | 1 | 2 | 2 | 11 |
Rathnayake et al. ( ) | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
Yousaf et al. ( ) | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
13 | 14 | 13 | 13 | 13 | 12 |
Scores: 0–2 (Baethge et al., 2019 ) .
Moreover, we aggregated the new studies to calculate the overall risk ratio (Balduzzi et al., 2019 ). A risk ratio (RR) >1 signifies that the intervention groups manifest better outcomes than the control ones. The packages meta and metasens within the freely available statistical environment R facilitated ratio calculation (Schwarzer et al., 2015 ; R Core Team, 2019 ).
Yielded works were parsed according to the target population (PWD and/or caregivers). In Table 5 , we classified the data from the reviews about PWD. In Table 6 , we instead reported the data about the new studies (i.e., sample size, characteristics, settings, and intervention length). In Table 7 , we summarized the data from the reviews about PWD caregivers. In particular, Tables 5 , ,7 7 display data about the types of conducted interventions, focus, used methodology, main results, and review conclusions. Hence, a thematic analysis of the outcomes was performed to classify the papers according to the aims underpinning the technological devices studied. Narrative synthesis integrates and appraises the quantitative and qualitative findings and the inclusion of studies using different methodologies. Two authors (AP and GO) reviewed and discussed the inclusion potential studies, and any discrepancy was resolved by a third reviewer (RC) through discussion until an agreement was reached. Thematic analysis was performed as an iterative process. Studies were read and re-read by the researchers, and key themes were identified for each paper and then amalgamated and integrated across studies.
Interventions for PWD.
Brando et al. ( ) | Analysis of the advantages and disadvantages associated with the implementation of technology into works with PWD and caregivers. | Literature Review. 30 studies, 27 on PWD. | Cognitive rehabilitation using technologies (videogames, VR setting, smartphone, computer and tablet). Cognitive assessment using digital tests. | Cognitive rehabilitation leads to a large generalization of the benefits. Significative outcomes on cognitive and depressive symptoms using videogames. Greater results on self-efficacy, perceived improvement, involvement and cognitive symptoms using VR rehabilitation than traditional activities. Positive effects on QoL using everyday technologies. Using digital tests for the assessment allow to standardize the administration process and the presentation of stimuli. | Cognitive rehabilitation using technologies has advantages over traditional rehabilitation. Further RCT studies are required to compare the advantages associated with different devices. |
Brims and Oliver ( ) | Analysis of the effectiveness of ATs in improving the safety of PWD. | Systematic Review and Meta-analysis. Three RCTs. | Interventions using devices (sensors and tech-armbands) to increase safety in domestic setting. | The probability of a fall occurring was 50% lower in the intervention group [risk ratio 0.50 95% CI (0.32, 0.78); Z = 3.03; = 0.002]. Significant fewer risky behavior in 1/3 studies ( < 0.001). No significant differences emerged between groups in care home admission, QoL and depressive symptoms. | Current evidence supports the use of safety AT by PwD. Further research is required to infer causality. |
Daly Lynn et al. ( ) | Analysis of the ATs used for PWD in residential care settings. | Systematic Review, 61 studies. | Interventions based on technologies. Telecare (23), light therapy (4), pet robots (12), simulated presence therapy (9), leisure activities (8) and ADL (5). | Telecare technologies – improvement in safety and increased PWD's autonomy. Light therapy – Improvement in circadian rhythms. Pet robots – decreased BPSD and depressive symptoms; increased social interactions. Daily living activities – positive effects on cognition, communication and physical activity. ADL – increased autonomy in personal hygiene, decreased stress using digital prompts. | Positive outcomes support the potential of ATs in dementia context. More standardized studies are required to explore the effectiveness of each device. |
Dove and Astell ( ) | Analysis of the available motion-based technologies in dementia context. | Literature Review. Thirty-one studies, section of 25/31 on PWD. | Interventions combining cognitive stimulation, physical activity and leisure activities using videogames based on motion sensors. | Motion-based technologies have benefits on general cognition, mobility, balance, fall risks, self-esteem, well-being and social health. | Motion-based technologies are feasible to stimulate PWD. A positive acceptability emerged. |
El-Saifi et al. ( ) | Analysis of interventions aimed at improving medication adherence in PWD. | Systematic Review, 20 studies, one relevant. | Intervention of tele-monitoring during day/night time. | Significative compliance in the intervention group (81%), compared to the control group (66%), < 0.05. Also, unmonitored patients' compliance fell of 12%. | Tele-monitoring was the only intervention able to increase PWD's compliance. Further standardized studies are required. |
Fleming and Sum ( ) | Analysis of the effectiveness of ATs in dementia care. | Systematic Review, 41 studies. | Interventions based on ATs to sustain: daily living, safety, therapies and telecare. | ATs for daily life were positively evaluated, but their usage decreased over time. - Safety ATs had potential benefits, but technical issues also emerged. – Positive outcomes on BPSD and circadian rhythms came out using technology-based therapy. -Telecare led to positive outcomes concerning cognitive training and medication adherence. | Mixed results emerged using ATs in dementia care. Further standardized studies are required to assess the effectiveness of technologies for PWD |
García-Casal et al. ( ) | Analysis of the effectiveness of computer-based cognitive interventions targeting PWD. | Systematic Review and Meta-analysis. | Computer-based interventions of cognitive training, cognitive rehabilitation, cognitive stimulation and cognitive recreation. | Moderate effects on cognition, assessed with MMSE and HDS-R (SMD −0.69; 95% CI = −1.02 a to 0.37; < 0.0001; I∧2 = 29%); greater effects on cognition of computer-based interventions compared to traditional interventions (SMD 0.48; 95% CI = 0.09–0.87; = 0.02; I∧2 = 2%). Small effects in depression, assessed with GDS and CES-D (SMD 0.47; 95% CI = 0.16 a 0.78; = 0.003; I∧2 = 0%). Moderate effects on anxiety, assessed with STAI (SMD 0.55; 95% CI = 0.07 a 1.04; < 0.03; I∧2 = 42%). No significant effects on IADL ( > 0.05). | Computer-based cognitive interventions have moderate effects on cognition and anxiety; small effects on depression. Computer-based interventions have greater effects over the traditional ones. Longer-term follow up are required to examine effects' retention. |
Klimova and Maresova ( ) | Analysis of the effectiveness of computer-based cognitive training for PWD and MCI. | Mini Review, section of four RCTs on PWD. | Computer-based cognitive training interventions. | 1/4 study showed improvement in episodic memory and abstract reasoning. 1/4 study was effective in delaying the progression of the cognitive impairment. 2/4 studies revealed no effects. | Mixed results emerged. Further standardized studies are required to examine the effectiveness of computer-based cognitive training on PWD. |
Lazar et al. ( ) | Analysis of the use of ICTs for facilitating reminiscence therapy. | Systematic Review, 44 studies. | Reminiscence therapy using technologies (videogames, multimedia and digital interfaces). | Technologies accommodate for motor and sensor impairments, using devices as earphones, image projectors or touchscreens. ICTs allow to compensate for memory deficits. Also, ICTs facilitate the administration process using clouds or telecare. | Technologies enrich reminiscence therapy for PWD. Further studies should focus on the effectiveness at different stages of dementia. |
Liapis and Harding ( ) | Analysis of the effectiveness of computer-based therapies for PWD. | Systematic Review, section of five relevant studies, one RCT. | Technology-based therapy interventions and leisure activities for PWD. | Interventions have been evaluated as feasible and enjoyable by PWD. No quantitative improvement in cognition emerged using MMSE. People with mild and moderate dementia preferred videogames; people with severe dementia preferred listening to music or watching videos. | Potential benefits emerged, but more standardized studies are required to examine the effectiveness of technology-based therapies for PWD. |
Lorenz et al. ( ) | Mapping technologies for PWD and caregivers, classified by function, target user and disease progression. | Rapid Review, interviews and blog analysis. Forty-seven studies. | Online psycho-social support, cognitive training, psycho-education and remote monitoring of the PWD. | Most technologies target people with moderate and severe dementia living in their homes are focused on safety. Most technologies for PWD living in care homes are focused on care delivery and therapies. Memory aids and daily living technologies mostly target people with mild dementia living in their homes. | Little evidence back up the practical application of the identified technologies. Further researches should examine the impact of a wide range of technologies on the daily living. |
Maia et al. ( ) | Analysis of interventions for PWD using ATs to sustain BADL. | Systematic Review, four studies. | Technology-based interventions to sustain BADL (safety, memory aid, monitoring, etc.). | Monitoring sensors has been evaluated as useful by PWD and caregivers; prompt systems facilitated medication adherence and finance management; navigation systems improved PWD's autonomy in movements. 1/4 study reported technical issues. | ATs are feasible to sustain PWD's BADL. |
Neubauer et al. ( ) | Analysis of the types of technologies used to manage wandering behavior in PWD. | Scoping Review, 12 studies. | Interventions targeting PWD using sensors, alarms and locators to manage wandering. | 26 types of technologies identified (GPS, sensors, alarms, Bluetooth, etc.). 67.7% of the devices were wearable. 7/12 studies reported positive results in managing wandering behaviors. The general acceptability was high. | Technologies can reduce risks associated with wandering behaviors and improve the autonomy in movements of PWD. Further studies are required to increase levels of evidence. |
Pinto-Bruno et al. ( ) | Analysis of the validity and the efficacy of ICT-based interventions to promote social health and an active aging. | Systematic Review, six studies. | ICT-based interventions of reminiscence therapy, leisure activities, cognitive and physical training. | Qualitative – technologies foster social participation in PWD. Quantitative – People in the intervention group made more choices [t = 3.6717, < 0.05] and sang more [t = 2.191, < 0.05] than the control group. People in the control group spent more time asking questions [t = 3.13, < 0.01] and initiated less conversations ( = 2.03, < 0.05) than the intervention group. | Initial positive evidence emerged using ICT interventions. Specific outcomes measure to assess social health and social participation are needed for future studies. |
Tyack and Camic ( ) | Analysis of the impact on well-being of touchscreen-based interventions for PWD. | Systematic Review, 16 studies. | Intervention using touchscreen devices to sustain reminiscence therapies, leisure activities, safety, communication and prompting systems. | Mixed results. Positive evidence on mood, involvement, perceived well-being and perceived satisfaction. A significant positive correlation emerged in one study between age and impact on mood (r = 0,46, < 0.05), with greater effects on older people. Benefits of social interaction with relatives and on the sense of mastery (technological skills and satisfaction increasing). | Touchscreen-based interventions can improve the psychological well-being of PWD. More rigorous future studies are needed. |
Yousaf et al. ( ) | Analysis of the evidence on the use of mHealth application for PWD. | Overview, 17 studies. | Interventions using mHealth Apps to sustain cognitive training, daily living, screening, safety, navigation and leisure activities. | Cognitive domain – available Apps target memory, communication, logical thinking, attention, language abilities and schedule. Screening domain – Apps target dementia detection and cognitive screening. Health/safety monitoring domain – Apps for fall detection and emergency help. Leisure domain – Apps for reminiscence therapy and socialization therapy. Navigation domain – Apps for tracking and location service. | Mobile health Apps are interactive, easy to use and independence promoting. These seems feasible AT intervention for PWD and caregivers. |
New studies for PWD.
Dethlefs et al. ( ) | Evaluation of the feasibility of computer-based cognitive stimulation using a spoken natural language interface. | Laboratory. | 23 people, 13 healthy elderly, 10 PWD (mild to moderate). | 20 min. | Pilot study non-RCT. | Computer-based cognitive stimulation (sorting, name recall, quiz and proverbs). | 8/10 PWD enjoyed doing the activities. Correct answers and reaction time were similar between experimental and control groups. Quiz and proverbs activities were preferred over sorting and name recall. | It seems possible to convey cognitive stimulation through spoken natural language interface. |
Favela et al. ( ) | Assess the benefits and limitations of using activity trackers for BPSD in dementia context. | Residential care facility. | 10 PWD (mild to moderate dementia). | 14 therapeutic sessions of 30 min. | Mixed methods design. | Cognitive stimulation therapy with the assistance of a social robot and activity trackers. | Activity tracker confirms or complements results obtained from the NPI-NH instrument or interviews with caregivers. | Activity trackers can help dementia research as they allow to gather data continuously and objectively. |
Hung et al. ( ) | Feasibility and acceptability of an intervention to support dementia. | Hospital. | Four PWD. | 14 sessions of 15 min. | Mixed methods design. | Simulated presence therapy (1 min video pre-recorded by a relative). | Positive results in reducing BPSD and increasing mood and treatment adherence. | Simulated presence therapy using can help PWD in hospital setting. Videos with a single person and a familiar voice are recommended. |
Lancioni et al. ( ) | Smartphone-based intervention to manage goal-directed, walker-assisted ambulation and object use. | Residential care facility. | 11 PWD (moderate dementia). | Multiple sessions of 3–5 min. | Mixed methods design. | Smartphone-based intervention to facilitate daily living. | Compared to a baseline of 0: - 2.9 correct target response of overall mean across participants; - over three indices of enjoyment/appreciation of overall mean across participants. | A smartphone-based intervention may be suitable to foster goal-directed, walker-assisted ambulation and object use. |
Inel Manav and Simsek ( ) | Analysis of the effects of reminiscence therapy based on internet videos. | Residential care facility. | 32 People with mild dementia. | 60 min, once a week for 3 months. | RCT. | Reminiscence therapy using selected videos vs. traditional therapy. | Significate differences between experimental and control groups: SMMSE (Standardized Mini-Mental State Examination) ( < 0.01); ARS (Apathy Rating Scale) ( < 0.01). | Reminiscence therapy using internet-based videos improved the cognitive functions and apathy levels of people with mild dementia. |
McCarron et al. ( ) | Analysis of the feasibility and utility of the Social Support Aid ( ) App for PWD. | Domestic setting. | 29 PWD, 19 MCI. | 6 months. | Pilot RCT. | Intervention using the App, combining a smartphone and a smartwatch, to help remembering names and relationships of familiar faces. | Utility – 3.10 (SD 0.63) pt. mean score using a 0–5 Likert scale with 15 items. No significant changes ( > 0.05) in quality of social interactions (PES-AD) or quality of life (DQoL). The App has been evaluated as too complex, stigmatizing and with an intricate enrollment process. | The App did not improve the quality of life and the quality of social interactions of people with memory loss. More practical devices are required. |
McGoldrick et al. ( ) | Analysis of the feasibility and utility of the memory aid App . | Domestic setting. | Three people with mild dementia. | 5 weeks. | Three single cases. | Intervention using the App to sustain memory in daily life. | Significant memory improvement ( < 0.01) in participant A (from 49 to 93% correct tasks post training) and participant B (from 69 to 95%). Participant C withdrew from the intervention. | Use of seems feasible and effective in supporting memory in everyday tasks. |
Moyle et al. ( ) | Analysis of the acceptability of telepresence robots in dementia care. | Laboratory. | Five PWD. | – | Mixed methods pilot study. | Videocall using the telepresence robot . | A sense of authenticity and social connection was experienced by participants. Significantly higher positive (mean score 18.77 ± 4.00) than negative affect (mean score 8.05 ± 1.76) on the I-PANAS-SF, and on the facial display subscale of the ODAS (positive – mean score 15.50 ± 3.51 vs. negative – mean score 4.00 ± 0.00). | Telepresence has potential use as it facilitates social connection in the dementia context. Further standardized studies are required to guide the implementation of telepresence in healthcare practice. |
Obayashi et al. ( ) | Analysis of the impact of age, gender and the stage of dementia on an intervention using communication robots. | Residential care facility. | 65 PWD. | 8 weeks. | Non randomized quasi-experimental study. | Social assistance intervention using com-robots and . | Participants aged ≥ 80 and in more advanced stage of dementia benefited more from the intervention ( < 0.05) than people younger and in less advanced stage. Selected items from the ICF (International Classification of Functioning, Disability and Health) scale were used. | The overall findings support the use of com-robots within the context of a care team for PWD. |
Interventions for caregivers.
Boots et al. ( ) | Analysis of the effectiveness, feasibility and quality of Internet interventions for informal caregivers of PWD. | Systematic Review. Twelve studies, three RCTs. | Informative websites providing information and strategies; peer-support/professional support through e-mails and phone calls. | Quantitative – small significant results in 6/12 on depressive symptoms, self-efficacy, perceived competence, decision-making and burden; Qualitative – positive outcomes on awareness, competence, mastery and perceived social support. Better outcomes for interventions combining informative websites with psycho-social support. | General positive outcomes emerged. Further researches are required due to small samples, not standardized designs and examined outcomes. |
Brando et al. ( ) | Analysis of the advantages and disadvantages associated with the implementation of technology into works with PWD and caregivers. | Literature Review (online-caregivers section of 3/30 studies). | Psycho-education online support through videoconference among peers. | Positive qualitative outcomes regarding online social support. | Few online interventions target caregivers. Initial evidence emerged. |
Dam et al. ( ) | Analysis of interventions targeting caregivers focused on social support. | Systematic Review (remote support section of 15 studies, 11 RCTs). | Informative/psycho-education websites; peer-support through online forums and videoconferences. | Qualitative – Positive outcomes for the perceived social isolation, social support and the relationship with the PWD. Benefits for the decision-making process using informative websites; benefits for stress, depression, self-efficacy and burden using videoconferences. | Positive qualitative outcomes emerged. Future research should use more standardized designs. |
Egan et al. ( ) | Analysis of online interventions targeting caregivers of PWD. | Systematic Review. Eight RCTs. | Psycho-education, psychotherapy (cognitive reframing and relaxation) and cognitive training using forums, videoconferences and selected videos. | Positive evidence on depressive symptoms 2/8, anxious symptoms 2/8, acquired skills 2/8 and self-efficacy. | Positive evidence emerged from heterogeneous designs; more standardized studies are required. No benefits emerged on the QoL. |
Godwin et al. ( ) | Analysis of the effectiveness of interventions targeting caregivers of PWD. | Systematic Review. Eight studies, four RCTs. | Informative websites; psycho-social support through forums, e-mails, chats and videos. | Positive benefits on depressive symptoms 4/8 and anxious symptoms 2/8. Mixed evidence on the social support. | Mixed results and heterogenous designs were found. Future standardized RCTs are required. |
Hopwood et al. ( ) | Analysis of the effectiveness of online interventions targeting caregivers of PWD. | Systematic Review. Forty studies, nine RCTs. | Psycho-social support in group of peers, using chats, forums, videoconferences and avatar 3D; training on the decision-making process. | Benefits on depressive and anxious symptoms; increased self-efficacy and QoL. Peer-support is more appreciated if conducted through videoconferences; informative interventions are preferred via websites rather than using handbooks. | Mixed results, but mostly positive, emerged. Future studies should better examine the caregivers' specific needs. |
Jackson et al. ( ) | Analysis of telephone-based and internet-based interventions targeting caregivers. | Systematic Review. Twenty-two studies, five internet-based. | Psycho-education, psychotherapy and psycho-social supportive interventions. | Qualitative positive results on depressive symptoms, general mental health and QoL. | Interventions combining different programs and devices had led to better outcomes. |
Leng et al. ( ) | Analysis of the efficacy of internet interventions in improving health of caregivers of PWD. | Systematic Review and Meta-Analysis. Seventeen RCTs. | Online psycho-social and psycho-educative support. | Significant positive results on depressive symptoms (SMD = −0.21; 95% CI −0.31 to −0.10; < 0.001), perceived stress (SMD = −0.40; 95% CI−0.55 to −0.24; < 0.001), anxious symptoms (SMD = −0.33; 95% CI−0.51 to −0.16; < 0.001) and self-efficacy (SMD = 0.19; 95% CI 0.05–0.33; = 0.007). No significant improvements were found in caregiver burden, coping, caregiver's reactions to behavioral symptoms and quality of life. | Internet-based interventions are generally effective at improving the health of family caregivers. |
Lorenz et al. ( ) | Mapping technologies for PWD and caregivers, classified by function, target user and disease progression. | Rapid Review, interviews and blog analysis. | Online psycho-social support, cognitive training, psycho-education and remote monitoring of the PWD. | Most technologies targeting carers are focused on memory sustainment and care delivery. | Little evidence back up the practical application of the identified technologies. Further researches should examine the impact of a wide range of technologies on daily living. |
Lucero et al. ( ) | Analysis of the effectiveness on health of ICT-based interventions targeting caregivers. | Systematic Review. Twelve RCTs, 6 internet-based. | Online psychotherapy; informative and educative interventions using websites; cognitive and physical training. | Internet interventions -> increased positive affect ( = 0.01), decreased concerns for PWD's behaviors ( = 0.02). Internet + telephone -> increased satisfaction ( = 0.015), physical activity ( < 0.01), self-efficacy ( < 0.01); decreased depressive symptoms ( = 0.02), anxious symptoms ( = 0.01) and stress ( < 0.05). | Positive benefits on health emerged from heterogeneous studies. A standardized methodology is required. |
McKechnie et al. ( ) | Analysis of computer-based interventions targeting caregivers of PWD. | Systematic Review. Twelve studies, six RCTs. | Psycho-education, psycho-social support among peers, psycho-social support with health care professionals. | Positive significant results ( < 0.05) on: depressive symptoms (four studies), general mental health (three studies), burden and stress (five studies), social support (one study), positive aspect of caregiving (one study) and self-efficacy (two studies). | Depression and burden were the most examined outcomes. Future studies should use a standardized methodology and examine the same outcomes. |
Parra-Vidales et al. ( ) | Analysis of online psycho-educational interventions targeting caregivers of PWD. | Systematic Review. Seven studies. | Online informative support, psycho-social support among peers and with health care professionals through chat and videoconference; cognitive training. | Positive results on self-efficacy (two studies), acquired knowledge (two studies), functional autonomy (one study), anxious/depressive symptoms (one study). | Outcomes examination is often not reported or not standardized. Online interventions have benefits on the social aspect and are usually perceived as positive. |
Rathnayake et al. ( ) | Analysis of interventions based on mHealth-App targeting caregivers. | Integrative Review. Seven studies. | Information, psycho-education, cognitive training and PWD's monitoring. | The main focus areas of mHealth App studies are categorized as: carer education, monitoring and cognitive training. | A theoretical model is required to guide the designing of mHealth App interventions. Further researches should focus more on psycho-education and psycho-social support. |
Ruggiano et al. ( ) | Analysis of technology-based interventions targeting caregivers of PWD living in rural areas. | Systematic Review. Thirty studies, 18 RCTs. | Online interventions focused on psycho-social support groups, psycho-education, psychotherapy, monitoring of mental and physical health. | Significant positive benefits ( < 0.05) on: depressive symptoms (five studies), anxious symptoms (two studies), other psycho-social aspect (six studies), as stress and perceived support. No benefits on self-efficacy and caregiver's skills emerged. | Few studies identified their sample population as living in rural areas. Future interventions should analyze the needs of the specific population. |
Scott et al. ( ) | Analysis of the effectiveness of TB-CBT interventions targeting caregivers of PWD. | Systematic Review. Four studies. | Cognitive-behavioral therapy using the internet and selected multimedia. | Small significant effects post-intervention of the TB-CBT on depression ( = 0.04); equivalent to the traditional CBT. | Future studies should analyze long-term effects of the TB-CBT. TB-CBT is an economical alternative to the traditional CBT. |
Waller et al. ( ) | Analysis of the acceptability, utilization and effectiveness of ICT-based interventions targeting caregivers. | Systematic Review. Online section of 19 studies. | Online psycho-education, cognitive training, psycho-social support among peers and with health care professionals. | Heterogeneous positive evidence emerged on general mental health, depressive symptoms, burden, positive aspect of caregiving and perceived social support. A positive acceptability emerged. | Potential benefits of ICT-based interventions emerged. High-quality studies are required to detect the most recommended types of intervention. |
Results are sorted into two main sections, one per target population involved. As shown in Table 3 , 12 out of the 30 reviews are related to online interventions targeting caregivers, 16 of them concern PWD, and two reviews target both PWD and caregivers. On the other hand, all of the nine new studies address PWD issues.
The quality assessments regarded the extent to which the 23 systematic reviews and seven reviews met the inclusion criteria.
All the systematic reviews received an AMSTAR score between 5 and 9, with a mean score of 7.4 (standard deviation = 1.2). All reviews were designed a priori (AMSTAR item 1); more than half of the analyzed works indicated that study selection and data extraction were performed by two authors minimum (item 2); all the reviews were based on electronic searches (item 3); 14 reviews included the status as an analyzed criterium (item 4); no reviews provided a list of excluded studies (item 5); all the reviews but one provided tables displaying the characteristics of the analyzed studies (item 6); 17 out of 23 reviews performed the study quality assessment (item 7); all the reviews but one based their conclusion on study quality levels (item 8); only four reviews performed a meta-analysis (item 9); 10 reviews reported publication bias (item 10), and 21 reviews discussed the conflicts of interest (item 11).
The reviews not analyzed via AMSTAR scores were subjected to the SANRA process (Brando et al., 2017 ; Dove and Astell, 2017 ; Klimova and Maresova, 2017 ; Neubauer et al., 2018 ; Lorenz et al., 2019 ; Rathnayake et al., 2019 ; Yousaf et al., 2019 ). Overall, the studies achieved a score of 11.1, with a standard deviation of 0.8. Across the items (i.e., justification of the article's importance for the readership, statement of concrete aims or formulation of questions, description of the literature search, referencing, scientific reasoning, and appropriate presentation of data), and no study scored 0.
Finally, we performed a risk ratio and a forest tree calculation to understand the effectiveness of the new studies. If the risk ratio was calculated higher than one, the study's technologies have an effective impact on the target ( Figure 2 ).
The figure displays new studies' effect size.
We classify the interventions targeting people with dementia into the four following macro-categories. Monitoring and security included studies with remote technologies aimed at detecting risky behavior and compensating for environmental obstacles. Daily living sustainment contains studies investigating devices supporting the PWD's cognitive functions. The therapeutic technology-based interventions were split between the studies that investigated cognitive aspects and the ones addressing psychosocial care.
The interventions regarding monitoring and security appear to be analyzed in 10 reviews and one new study from our analysis. Lorenz et al. ( 2019 ) underline how technology targeting PWD living in their homes is mainly aimed at monitoring them or increasing the environment's security. The most used devices for achieving this purpose are video cameras. These devices might be used to ascertain the person in real time or record tapes for later analysis (Lorenz et al., 2019 ; Yousaf et al., 2019 ). The included reviews also reveal how video monitoring allows us to increase medication compliance in people with dementia (Fleming and Sum, 2014 ; El-Saifi et al., 2018 ). Video monitoring also leads to relevant benefits inside care homes, and it happens when it is combined with bed sensors. Both these technologies allow us to reduce intrusive check-ups overnight from healthcare professionals by avoiding sudden and unnecessary awakenings. Despite a few technical issues and the false alarms that emerged during the studies, the devices lead to a positive quality of life-related outcomes and high levels of acceptance from either PWD, their caregivers, and staff members (Maia et al., 2018 ; Daly Lynn et al., 2019 ). Finally, one review suggests the adoption of the actigraphy technique as having potentially worth in helping to monitor people in care home settings (Favela et al., 2020 ).
Other relevant devices for monitoring are the position trackers and locators. These are usually based on GPS technology featuring most of the ordinary smartphones. Neubauer et al. ( 2018 ) analyzed monitoring technologies for PWD and reported that GPS devices are usually implemented in wearable items, such as belts or wristwatches. CANDEROID , for example, is a system based on a wrist sensor combined with a smartphone App allowing the caregiver to monitor and track the position of the PWD in real-time (Brando et al., 2017 ). Benefits to the perceived security and quality of life emerge from using these technologies by PWD and informal caregivers (Lorenz et al., 2019 ). Moreover, as some of the devices imply the active roles of PWD, they and their caregivers can contact each other to ask for mutual information or help (Lorenz et al., 2019 ).
Aside from the beneficial impact these devices offer, some technical issues can emerge in GPS-based technologies, such as position inaccuracy or signal instability (Fleming and Sum, 2014 ). However, due to the technological progression, these problems have been fixed insomuch as they become a useful aid in managing wandering behaviors (Neubauer et al., 2018 ; Lorenz et al., 2019 ).
Among security systems, many studies focus on smart-homes technology aimed at reducing risk and increasing the quality of life of the home denizens (Fleming and Sum, 2014 ; Tyack and Camic, 2017 ; Neubauer et al., 2018 ; Brims and Oliver, 2019 ; Daly Lynn et al., 2019 ; Lorenz et al., 2019 ). In domestic settings, automatic sensors are used to detect sudden heat changes, gas leakages, forced doors opening, and so on or to facilitate the management of light switches and water valves (Lorenz et al., 2019 ). An example is the COGNOW program, which capitalizes on a central control panel capable of administrating all the different technological tools implemented in the house (Tyack and Camic, 2017 ).
Another relevant topic is related to the use of technology for fall prevention. Positive outcomes are observed both with basic support, such as light pathways on the ground or bright handrails, and with a more complex system, such as electronic armbands combined with modern sensors, which send alarms to an assistance center in case of an emergency. Specifically, three randomized controlled studies show that the fall risk featuring the experimental groups is 50% lower than those expressed in the control groups. Moreover, it emerges that the use of ATs decreases the number of risky behaviors, as leaving the home incautiously might result in negative consequences. In contrast, for what concerns the quality of life and the reduced institutionalization, no significant positive outcomes emerged from these studies (Brims and Oliver, 2019 ).
In care home settings, tagging systems can be implemented: they can be envisioned as intangible spatial barriers that PWD should not overstep during specifically scheduled times; otherwise, an alarm would start ringing (Fleming and Sum, 2014 ). Tagging technologies are well-accepted both by PWD and healthcare professionals, as they are less obtrusive than physical constraints (Neubauer et al., 2018 ). Moreover, tagging systems increase both the perceived and the actual safety (Daly Lynn et al., 2019 ). In contrast, the devices that limit people's autonomy, such as electronic lock doors, are not well-accepted, as they are perceived as dehumanizing despite the improved safety of PWD (Neubauer et al., 2018 ). In terms of psychological outcomes, non-constraining technologies show positive benefits on the levels of PWD's perceived well-being and anxiety (Neubauer et al., 2018 ). Lastly, the reviews show that the alarms placed between the rooms are associated with positive qualitative outcomes in care home settings (Yousaf et al., 2019 ).
The issues of interventions regarding daily living sustainment using ATs appear in seven reviews and four new studies from our analysis. Daily living sustainment is the primary purpose of ATs with PWD (Lorenz et al., 2019 ). Indeed, ATs can support cognitive functions, such as different memory types, spatio-temporal orientation, and language. For what concerns the prospective memory, devices like digital organizers and electronic reminders can improve the quality of life of PWD (Brando et al., 2017 ; Lorenz et al., 2019 ; Lancioni et al., 2020 ). An example is the App MindMate , an electronic calendar designed to help PWD remember the daily schedule. The App has been evaluated arranging simple tasks, such as “call the researcher,” which people with dementia had to pursue at scheduled times. After 5 weeks of intervention, MindMate showed benefits on the prospective memory of the PWD (McGoldrick et al., 2019 ). Other devices that are used to sustain prospective memories are pill dispensers. Controversial outcomes are associated with these technologies: some authors describe them as functional (Fleming and Sum, 2014 ; Maia et al., 2018 ), and others suggest that their usage is too complicated for PWD (Daly Lynn et al., 2019 ).
Regarding procedural memory, instead, positive outcomes emerge from using prompting systems. These consist of tools giving step-by-step prompts, either in visual or vocal forms, to guide PWD to achieve daily tasks as cooking, washing their hands, and setting the table correctly (Brando et al., 2017 ; Maia et al., 2018 ; Daly Lynn et al., 2019 ). Moreover, some potential benefits emerge from using mobile Apps to guide practical actions (Lancioni et al., 2020 ).
There is little evidence to endorse the application of ATs to sustain the memory of faces. The only identified intervention in this area concerns a randomized controlled trial (RCT) using an App called SSA (“ Social Support Aid ”). The App combines a smartwatch camera with an online database containing preloaded faces labeled with a personalized tag, such as “Emma, daughter.” The system aims to match the faces included in the database and the ones caught by the smartwatch camera. Once the match has finished, it notifies the person with the assigned tag in case of a positive match. PWD evaluates the App as too complicated, and it does not increase users' quality of life (McCarron et al., 2019 ).
For what concerns the spatio-temporal orientation, ATs are useful to sustain daily living. Apart from the already described electronic calendars, other devices are employed with PWD, such as monitors capable of harmonizing night-time awakenings in care home settings. These devices are usually placed in front of the PWD's bed, showing recommendations like “it's night, let's go back to sleep” and similar (Lorenz et al., 2019 ; Moyle et al., 2019 ). Moreover, it emerges that robot-assisted navigation can lead to positive outcomes to increase PWD's ability to move autonomously (Maia et al., 2018 ).
Regarding language, positive outcomes derive mainly from using smartphones in functional manners. In particular, improvements in the semantic component of language emerge when PWD use their smartphones to take notes of words or navigate the internet when they do not remember a definition (Brando et al., 2017 ). In the same fashion, Lorenz et al. ( 2019 ) report positive daily PWD experiences using SIRI , a famous virtual assistant. More evidence emerges regarding technologies to support the communication process: PWD answers more frequently to the incoming calls when the telephones are adapted to their perceptual and cognitive needs. Differently, these devices cannot improve the quality of life of the users ultimately, as they cannot solve broader problems such as remembering to call or whom the PWD have spoken to (Topo et al., 2002 ; Fleming and Sum, 2014 ).
Another piece of evidence supports the employment of telepresence robots to sustain social connections. It emerged from the pilot study led by Moyle et al. ( 2019 ) using the com-robot Giraff in an experimental setting with five PWD. Giraff is a wheel-based, remotely controlled device carrying a tablet that can convey videocalls. Giraff is also of human height, and the upper part of the robot may also be bent forward or tilted left and right, simulating social head gestures. The devices were evaluated as realistic and useful by four out of five PWD. Furthermore, the most appreciated aspect was the possibility to control Giraff remotely to make it move around the room.
Moreover, even some social aspects can be sustained by smart-home devices. Systems like the PAL4-Dementia allow both to manage the technological tools implemented in the house and start video calls with relatives or healthcare professionals (Tyack and Camic, 2017 ).
Although we observe that ATs interventions usually lead to positive outcomes for what concerns daily living, there is also a reported discrepancy between the experimental research and the actual uptake of the devices in everyday life. In fact, in this regard, some authors noted that the use of technology decreases in the follow-up because of disease development, limited financial resources, time- and burden-related constraints (Fleming and Sum, 2014 ; Lorenz et al., 2019 ).
From our analysis, the interventions regarding therapeutic support emerge in 13 reviews and three new studies. Technological devices, Apps, videoconferences, and software, convey and support different intervention categories targeting the PWD's cognitive functions, i.e., cognitive training, stimulation, and rehabilitation. García-Casal et al. ( 2017 ) carried out a review and meta-analysis of 12 computer-based cognitive intervention studies. Once they have analyzed the outcoming effects regardless of the intervention category, they report intermediate results regarding cognition and anxiety and small impacts concerning depression. In contrast, no consequences were observed in terms of the PWD's daily activities.
For what concerns cognitive training, mixed outcomes emerge among the analyzed reviews targeting people with dementia. In a review of four RCTs, Klimova and Maresova ( 2017 ) reported that half of the studies do not produce significant outcomes. One of them reported benefits on episodic memory and abstract reasoning, while the remaining study highlighted that computer-based cognitive interventions can slow down cognitive decline. Moreover, it emerges that the mHealth App can train, monitor, and self-assess the performance achieved in all the cognitive functions. Indeed, the Apps help PWD function better in their daily lives, especially if the users accept it because it is intuitive (Yousaf et al., 2019 ).
Technological devices mainly support cognitive stimulation interventions since stimulation is the most appreciated activity by PWD (Liapis and Harding, 2017 ; Daly Lynn et al., 2019 ), and it leads to an extensive generalization of the benefits (Brando et al., 2017 ).
Our analysis suggests that different stages of the dementia pathway are associated with preferred stimulation activities. People with mild or moderate dementia tend to prefer challenging tasks, such as the ones provided via videogames modality. Among videogames, an example is the software Big Brain Academy , which has a positive impact on perception, memory, logical reasoning, and general cognitive functioning (Brando et al., 2017 ). On the other hand, people with severe dementia prefer more static and sense-based activities, such as listening to music or watching videos (Liapis and Harding, 2017 ).
Besides, implementing a technological component in stimulation interventions allows us to compensate for sensory deficits thanks to apposite designed interfaces. For example, headphones and image projectors boost the auditory and the visual apparatus, respectively (Lazar et al., 2014 ). Additionally, many benefits emerge using innovative input systems, such as touchscreens, motion-sensors, and voice user interfaces. Tyack and Camic ( 2017 ) report that the interventions based on intuitive touchscreens led to positive mental health outcomes, perceived well-being, and satisfaction, especially in older people. Moreover, the request of learning how to use modern devices increases PWD's involvement, pride, and sense of mastery (Tyack and Camic, 2017 ). Tablets are also frequent in these programs of intervention. By reproducing multimedia or allowing PWD to express their art capacity, tablets support behavioral symptoms management while sustaining people's creative skills. The App ExPress Play , for example, can generate chord-based music thanks to the touchscreen (Tyack and Camic, 2017 ; Yousaf et al., 2019 ). In a similar vein, while studying the software recognizing and synthesizing human voices, Dethlefs et al. ( 2017 ) report that PWD appreciate voice user interfaces, as can be seen by increased involvement in computer-based cognitive stimulation programs. Again, devices based on motion sensors are highly recommended for PWD because they can compensate for the issues arising from memorizing device button-keys (Dove and Astell, 2017 ). Moreover, benefits emerge regarding the PWD's cognitive decrease associated with the disease, while enhancing their moods positively, as they stimulate people's movements (Dove and Astell, 2017 ).
For what concerns cognitive rehabilitation, instead, the literature shows that virtual reality can be a component used to recreate settings that are familiar to PWD or to let them practice with the execution of daily activities, such as cooking or shopping at the grocery shop. The adoption of the virtual setting produces better outcomes on the general cognitive functioning, learned skills, self-efficacy, and motivation, with respect to practicing the same activities within traditional environments. Moreover, by combining virtual reality headset and controller, visuospatial orientation and autonomous movements can increase (Brando et al., 2017 ).
Finally, some evidence related to therapeutic interventions remotely conducted using videoconferences emerge from the literature search. It is revealed that online memory clinics are positively accepted by PWD and mostly by living in rural areas (Weiner et al., 2011 ; Lorenz et al., 2019 ). Also, two RCT studies highlight that remote cognitive interventions produce benefits on PWD's general cognitive functioning, attention, memory, calculus, and phonemic and semantic verbal expression (Jelcic et al., 2014 ). Furthermore, it is revealed that some PWD and their caregivers express specific preferences for remotely conducted interventions since they limit laborious transfers (Fleming and Sum, 2014 ).
From our analysis, we yield that technological devices can support psychosocial interventions such as reminiscence, light therapy, multisensory therapy, simulated presence therapy, and therapy based on social robots. Lorenz et al. ( 2019 ) point out that technologies can easily convey psychosocial interventions in home-care settings. For what concerns reminiscence therapy, technological devices might be useful as they allow you to select personalized multimedia and adequately stimulate the emotional memory (Inel Manav and Simsek, 2019 ). For example, in an RCT focused on the effects of the reminiscence therapy, YouTube videos obtain positive results that concern both PWD's cognition and mood (Inel Manav and Simsek, 2019 ). Moreover, by integrating a camera in smart-watches devices, it becomes possible to gather pictures or videos during daily living. The collected multimedia becomes useful vehicles during reminiscence therapy sessions (Lazar et al., 2014 ). Again, as soon as reminiscence therapy meets technological devices, such as with touchscreen interfaces, people's involvement increases. Indeed, people can autonomously feel competent and capable of handling the digital contents (Liapis and Harding, 2017 ; Tyack and Camic, 2017 ; Yousaf et al., 2019 ). Besides, the increased confidence in modern devices represents an opportunity to close the gap between social generations (Yousaf et al., 2019 ). The “ Computer interactive reminiscence and conversation aid – CIRCA ,” i.e., a program targeting the dyad PWD-caregiver, has led to positive results in the decision-making process and the social involvement and in particular for singing activities (Pinto-Bruno et al., 2017 ; Tyack and Camic, 2017 ).
Finally, technology allows to overcome environmental barriers and to conduct therapies from a remote position because they provide the opportunity to both communicate and access the same multimedia simultaneously (Lazar et al., 2014 ; Dethlefs et al., 2017 ). Dyads positively accept remotely delivered therapies because they can ameliorate the management of behavioral symptoms (agitation, irritability, and insomnia) (Lazar et al., 2014 ). In particular, MyBrainBook is an online platform aimed at conveying reminiscence therapy. By connecting PWD and their relatives and friends, they can still feel part of a social network. Moreover, as it capitalizes on a cloud environment to gather personalized content, it is useful when implementing the process of reminiscence (Dethlefs et al., 2017 ). Positive results also came out from interventions using tools to start the required applications for the therapies remotely. Such a strategy allows us to compensate for the lack of technological skills featuring some people (Yasuda et al., 2013 ; Lazar et al., 2014 ).
As it emerges for the reminiscence, even light therapies can be aimed at managing behavioral symptoms and they are mainly conducted in home-care settings. In particular, positive effects followed in the forms of agitation, circadian rhythms, and well-being (Fleming and Sum, 2014 ; Daly Lynn et al., 2019 ). Similar benefits come out using multisensory therapies, especially with the Snoezelen Room, which leads to positive results regarding well-being, and behavioral agitation. Despite this evidence, multisensory therapies have emerged to produce fewer effects than the immersion in real natural environments (Fleming and Sum, 2014 ).
Simulated presence therapies capitalize on technological devices; they involve videos that were pre-recorded by a family member. The videos recorded using spontaneous language lead to well-being improvement, fewer phone-calls during the night-time, and increased adherence to medical recommendations and compliance (Fleming and Sum, 2014 ; Hung et al., 2018 ; Daly Lynn et al., 2019 ).
The therapies based on social robots appear to produce contrasting evidence (Daly Lynn et al., 2019 ). Fleming and Sum ( 2014 ) highlight that adding a mechanical component does not lead to better improvements than therapies using regular pet plushies. Other authors, instead, report positive benefits on behavioral agitation, depressive symptoms, and social interactions, using the pet robots PARO, NeCoRo, AIBO , and CuDDler (Daly Lynn et al., 2019 ). On the other hand, using the communication robots COTA and PALRO , positive results emerge even with regards to the functional autonomy of PWD, especially for people over 80 with severe dementia (Obayashi et al., 2020 ).
A total of six studies out of 10 did not use a control group. All of them but McCarron et al. ( 2019 ) reported the positive effects of technologies. The heterogeneity of the study pool was almost significant (See Figure 2 ). Once all the studies without control groups, with the addition of McCarron et al., were removed, the remaining three works showed a homogeneous risk ratio [RR = 1, 95%- CI: 0.93; 1.08]. As described previously, the study of McCarron et al. showed that no positive social engagement emerged in the 20 people enrolled in the smart-watch use compared to the 28 counterparts.
The interventions targeting caregivers capitalize on different web interfaces and services. In particular, Hopwood et al. ( 2018 ) highlight how online interventions might be delivered either via private or public services. Private services include online tools available only for a restricted number of people, with access granted upfront invitation and/or after registration. These systems allow for the exchange of personal information, ensuring privacy protection. From our analysis, e-mails (Godwin et al., 2013 ; Boots et al., 2014 ; McKechnie et al., 2014 ; Dam et al., 2016 ; Hopwood et al., 2018 ), chats (Boots et al., 2014 ; McKechnie et al., 2014 ; Dam et al., 2016 ; Parra-Vidales et al., 2017 ; Waller et al., 2017 ; Hopwood et al., 2018 ) and videoconferences (Boots et al., 2014 ; McKechnie et al., 2014 ; Dam et al., 2016 ; Scott et al., 2016 ; Brando et al., 2017 ; Parra-Vidales et al., 2017 ; Waller et al., 2017 ; Egan et al., 2018 ; Hopwood et al., 2018 ; Ruggiano et al., 2018 ; Lorenz et al., 2019 ) emerge to feature the interventions for caregivers. Moreover, the evidence applying an online virtual setting with 3D avatars was useful to help caregivers communicate with each other while preserving a sense of privacy (O'Connor et al., 2014 ; Hopwood et al., 2018 ).
Public services include free-access content at everyone's disposal, such as the frequently used informative websites (Godwin et al., 2013 ; Boots et al., 2014 ; McKechnie et al., 2014 ; Brando et al., 2017 ; Parra-Vidales et al., 2017 ; Hopwood et al., 2018 ; Ruggiano et al., 2018 ; Lucero et al., 2019 ). Moreover, other services, such as blogs (Hopwood et al., 2018 ), forums, or selected social networks (Godwin et al., 2013 ; Boots et al., 2014 ; McKechnie et al., 2014 ; Dam et al., 2016 ; Parra-Vidales et al., 2017 ; Egan et al., 2018 ; Hopwood et al., 2018 ; Lorenz et al., 2019 ) and multimedia (Boots et al., 2014 ; McKechnie et al., 2014 ; Jackson et al., 2016 ; Scott et al., 2016 ; Brando et al., 2017 ; Egan et al., 2018 ; Hopwood et al., 2018 ; Ruggiano et al., 2018 ; Lucero et al., 2019 ) might be either private or public, as a function of the privacy settings set by the admin. Finally, it emerges that mHealth Apps for smartphones or tablets are used in online-based interventions for caregivers of PWD (Brando et al., 2017 ; Rathnayake et al., 2019 ).
Regarding the aims featuring the AT-based interventions, the analysis of the reviews suggests that we group the intervention aims into six groups: informative, psycho-education programs, psychosocial support, psychotherapy, cognitive training, and physical training. Informative interventions are deployed through websites providing information on many issues, such as the treatment and the management of dementia, the risks associated with the disease, and the implication on caregivers' health. Moreover, they provide useful links and contact information for community services (Godwin et al., 2013 ; Rathnayake et al., 2019 ) and are usually part of multicomponent programs (Boots et al., 2014 ; Brando et al., 2017 ; Hopwood et al., 2018 ; Lorenz et al., 2019 ).
Psycho-education programs mainly target caregivers' strategies and coping skills. Private services are preferred over public ones. When people seek help from healthcare professionals, such assistance can arrive through videoconferences or by watching recommended and personalized educative videos (Jackson et al., 2016 ; Parra-Vidales et al., 2017 ; Waller et al., 2017 ). Also, the mHealth App attempt was for the same purpose (Rathnayake et al., 2019 ). As it happens for informative interventions, even the psycho-education ones are often part of multicomponent programs together with psychosocial support or psycho-therapeutic interventions (Boots et al., 2014 ; McKechnie et al., 2014 ; Scott et al., 2016 ; Brando et al., 2017 ; Egan et al., 2018 ; Ruggiano et al., 2018 ; Lorenz et al., 2019 ; Lucero et al., 2019 ).
Psychosocial supportive interventions are focused on the improvement of caregivers' emotional well-being and social health through videoconferences among small groups of peers, chats, e-mails, or self-administered personalized multimedia content (Boots et al., 2014 ; McKechnie et al., 2014 ; Dam et al., 2016 ; Jackson et al., 2016 ; Waller et al., 2017 ; Egan et al., 2018 ; Hopwood et al., 2018 ; Ruggiano et al., 2018 ; Lorenz et al., 2019 ; Lucero et al., 2019 ). The participation of a healthcare professional is not mandatory (Hopwood et al., 2018 ).
Psycho-therapeutic interventions usually aim to reduce depressive or anxious symptoms and dealing with caregivers' burdens. The cognitive-behavioral approach is popular; meanwhile, cognitive reframing and relaxation are the most frequently applied techniques. For these interventions, the preference for the videoconferences has overcome the one for written communication (Boots et al., 2014 ; McKechnie et al., 2014 ; Jackson et al., 2016 ; Brando et al., 2017 ; Egan et al., 2018 ; Lorenz et al., 2019 ). Besides, the monitoring of the caregiver's emotional state is an essential aspect of the process: through the mHealth App, well-being-related symptoms can be self-assessed and shared with care providers together with other medical records (Brando et al., 2017 ; Rathnayake et al., 2019 ).
Interventions for caregivers based on cognitive and physical training promote healthy lifestyles and future healthy aging. The cognitive practice usually targets decision-making and problem-solving processes (Boots et al., 2014 ; Waller et al., 2017 ; Egan et al., 2018 ; Ruggiano et al., 2018 ; Lorenz et al., 2019 ). On the other hand, physical training pertains to easy motor exercises (Ottoboni et al., 2018 ; Ruggiano et al., 2018 ; Lorenz et al., 2019 ; Lucero et al., 2019 ). Both types of training are delivered to small groups of users via videoconferences with healthcare professionals or via written chats or forums (Hopwood et al., 2018 ). Finally, cognitive function and physical health might be self-assessed using specific mobile Apps (Brando et al., 2017 ; Rathnayake et al., 2019 ).
Overall, the literature suggests the need to match aims, interventions, and interfaces. Once the purposes are defined through needs and capacity assessment, interventions obtain better results if they fit with the appropriate interfaces (Ajzen, 1985 ). Informative websites are preferred over handbook instructions and seem to be the best way to provide fast and straightforward resources (Hopwood et al., 2018 ). Differently, videoconferences are the preferable interventions to improve caregivers' emotional well-being and to communicate in small groups of peers either in public forums or through private messaging (Dam et al., 2016 ; Parra-Vidales et al., 2017 ; Waller et al., 2017 ; Hopwood et al., 2018 ). Moreover, peer support seems to entail the best way to improve decision-making processes and increase caregivers' confidence in their choices. Finally, it appears usually more appreciated when it integrates multicomponent programs (Godwin et al., 2013 ; Hopwood et al., 2018 ).
As seminally suggested elsewhere (Moniz-Cook and Manthorpe, 2009 ), even here, the interventions that are capable of combining different modalities lead to better outcomes. The combination of videoconferences with phone calls and/or informative websites produces higher positive effects than those obtained using a singular channel. In particular, positive outcomes emerged related to emotional well-being, self-efficacy and perceived satisfaction, and self-efficacy and perceived satisfaction (Boots et al., 2014 ; Jackson et al., 2016 ; Lucero et al., 2019 ). Indeed, in general, interventions provided positive results. The main benefits regard emotional well-being (depression, anxiety, stress, and burden), learned skills (decision making, knowledge, self-efficacy, and strategies), and social aspects (perceived support and positive aspects related to caregiving, such as bonding with your relative; (McKechnie et al., 2014 ; Dam et al., 2016 ; Egan et al., 2018 ; Ruggiano et al., 2018 ). Moreover, despite the few quantitative analyses and the limits concerning the adopted methodologies, results highlighted the benefits online interventions have for what concerns caregivers' quality of life (Boots et al., 2014 ; Waller et al., 2017 ; Leng et al., 2020 ).
The present review analyzes the role of technology in the interventions addressed toward both PWD and their caregivers. The final summary aims to provide tangible support to decision-makers in deciding which ATs may better compensate for the dysfunctionalities featuring many dementia contexts.
The quality of the analyzed literature was high. Both the AMSTAR and the SANRA scores returned adequate standard levels, notwithstanding the reported methodologies' heterogeneous quality.
From our analysis, it emerges that in dementia contexts, the use of ATs is increasing. Such technologies can facilitate daily living, either for what concerns daily activity and the possibility to connect people that are geographically distant. Connections are particularly relevant in the case of difficulties associated with psychological states, personal injuries, and orographic features. In all these cases, technology can compensate for the limitations imposed on traditional human interactions. It represents a useful resource to stay in touch with relatives, friends, and physicians or therapists, too (Novitzky et al., 2015 ; Cheung and Peri, 2020 ).
In this light, ATs can become useful even to face social distancing occurring during further pandemic waves. Monitoring technologies, such as video-cameras or GPS-based systems, meet the visit restrictions and thus contagion by reducing the number of check-ups both in residential settings and PWD's homes (Fleming and Sum, 2014 ; Brando et al., 2017 ; Tyack and Camic, 2017 ; Neubauer et al., 2018 ; Lorenz et al., 2019 ). Simultaneously, ATs can compensate for the distress associated with the resulting isolation through communication tools designed to keep people remotely “in-touch.” Phone-calls, chat interfaces, videoconferences, and remote therapies, for example, can connect family members, physicians/therapists, and communities of peers (Weiner et al., 2011 ; Jelcic et al., 2014 ; Dethlefs et al., 2017 ; Lorenz et al., 2019 ; Cheung and Peri, 2020 ). Moreover, telepresence robots may be useful surrogates during isolation by increasing daily stimulation activities. In the same vein, even multimedia, Apps offering interactive gaming or automatic prompting systems can either stimulate cognitive functions or sustain PWD daily living and instrumental activities (Brando et al., 2017 ; Tyack and Camic, 2017 ; Daly Lynn et al., 2019 ; Moyle et al., 2019 ). However, people with dementia are not the only ones who can take advantage of different technological tools. Remote ATs can involve PWD's caregivers by providing them with several types of supportive programs, which, in turn, emerged to have many positive outcomes. If, on the one hand, the number of online or remote supportive tools targeting PWD are few, they are positively evaluated both by PWD and their caregivers (Weiner et al., 2011 ; Lazar et al., 2014 ; Lorenz et al., 2019 ; Moyle et al., 2019 ). Our analysis also shows some limitations in the existing AT-related literature. The first one is concerned with using heterogeneous methodologies to assess the impact of the use of ATs. Specifically, several devices deliver different types of interventions, the sample size is usually small, research designs barely standardized, and the outcomes were not enough systematized. Unfortunately, such limitations have not improved with time. Both heterogeneity and effect sizes featuring the latest studies showed that technologies need more controlled research to reveal their effectiveness. Furthermore, our analysis shows a possible bias regarding the population defined as the interventions' primary target. For example, many of the interventions monitoring PWD to offering them security services are often described as helpful “for caregivers.” Even though these technologies may also assist the caregiving process, we think that they should be labeled as “for PWD,” as the actual label does not consider functional autonomy levels still active. The security devices can be used autonomously by PWD until their autonomy has not yet been severely compromised. In this vein, Lorenz et al. ( 2019 ) reported a meaningful blog post written by a person with dementia. The post describes how he felt about the transition between the active and passive roles in domestic alarms management. In the first phase of the disease, notifications supported a person's autonomy until he could recognize the different sounds. Later, due to the disease's progression, the person could not understand the source of the sounds anymore. Therefore, when a caregiver's assistance becomes necessary to manage the technological devices, it may be more appropriate to label the technology as “for caregivers”: it cannot support any longer the PWD but, instead, the caregiver.
Besides what was discussed, it is also relevant to mention that the theoretical models underpinning technological offers need improvement. Only the review of Rathnayake et al. ( 2019 ) highlighted the theoretical backgrounds upon which the designing process of the Apps was based. On top of this, just two of the studies reviewed by them reported a theoretical model. This evidence confirms the need to increase the number of studies on technology that bases their hypothesis on theoretical models. Such an improvement would impact the rate of studies reproducibility, and it can also foster the capability of the research to disentangle which factors cause the observed effects (Kennelly, 2011 ). These limitations are associated with two consequences. Firstly, the single outcomes featuring each intervention are hard to disentangle and to generalize. Secondly, there is a significant gap between the theory underpinning the research and the implementation of the devices in everyday life, which is due to a lack of attention toward time-related factors and organizational determinants (Christie et al., 2018 ). Indeed, the inadequate follow-ups and insufficient consideration of the person's ongoing adaptation process provoke an over-time decline in the usage of ATs in the post-trial phases (Christie et al., 2018 ). Finally, the design of interventions should focus more on developing user-friendly technologies that can be personalized and updated by respecting users' evolving needs. Additionally, there is a limited interest in innovation supplied by national and local health organizations, mainly when the elderly are the target of the technology (Christie et al., 2018 ). Hence, it is necessary to regularly update the research to develop interventions able to exploit the maximal potential of modern technologies and supportive organizational plans aimed at overcoming the barriers experienced by healthcare professionals and the devices' final users (Meiland et al., 2017 ).
One of the limitations affecting the present work consists of the use of a heterogeneous methodology chosen. Specifically, to timely respond to the pandemic, we primarily decided to include in this work reviews of reviews. As we noticed that no review discussed the recent outbreak, we welcomed new studies reporting how the technology can support both PWD and caregivers. The second main limitation regards the selection criteria since no we did not analyze any gray literature sources. Although such a decision might have prevented additional evidence from emerging, it secured certified standards.
Author contributions.
AP performed the literature search, outlined the results, and drafted the manuscript. RC discussed the search outcomes and supervised the process. IC and MV reviewed the manuscript. GO performed the literature search, discussed and reviewed the results, drafted the document, and managed the operations. All authors contributed to the article and approved the submitted version.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Researching the white paper:.
The process of researching and composing a white paper shares some similarities with the kind of research and writing one does for a high school or college research paper. What’s important for writers of white papers to grasp, however, is how much this genre differs from a research paper. First, the author of a white paper already recognizes that there is a problem to be solved, a decision to be made, and the job of the author is to provide readers with substantive information to help them make some kind of decision--which may include a decision to do more research because major gaps remain.
Thus, a white paper author would not “brainstorm” a topic. Instead, the white paper author would get busy figuring out how the problem is defined by those who are experiencing it as a problem. Typically that research begins in popular culture--social media, surveys, interviews, newspapers. Once the author has a handle on how the problem is being defined and experienced, its history and its impact, what people in the trenches believe might be the best or worst ways of addressing it, the author then will turn to academic scholarship as well as “grey” literature (more about that later). Unlike a school research paper, the author does not set out to argue for or against a particular position, and then devote the majority of effort to finding sources to support the selected position. Instead, the author sets out in good faith to do as much fact-finding as possible, and thus research is likely to present multiple, conflicting, and overlapping perspectives. When people research out of a genuine desire to understand and solve a problem, they listen to every source that may offer helpful information. They will thus have to do much more analysis, synthesis, and sorting of that information, which will often not fall neatly into a “pro” or “con” camp: Solution A may, for example, solve one part of the problem but exacerbate another part of the problem. Solution C may sound like what everyone wants, but what if it’s built on a set of data that have been criticized by another reliable source? And so it goes.
For example, if you are trying to write a white paper on the opioid crisis, you may focus on the value of providing free, sterilized needles--which do indeed reduce disease, and also provide an opportunity for the health care provider distributing them to offer addiction treatment to the user. However, the free needles are sometimes discarded on the ground, posing a danger to others; or they may be shared; or they may encourage more drug usage. All of those things can be true at once; a reader will want to know about all of these considerations in order to make an informed decision. That is the challenging job of the white paper author. The research you do for your white paper will require that you identify a specific problem, seek popular culture sources to help define the problem, its history, its significance and impact for people affected by it. You will then delve into academic and grey literature to learn about the way scholars and others with professional expertise answer these same questions. In this way, you will create creating a layered, complex portrait that provides readers with a substantive exploration useful for deliberating and decision-making. You will also likely need to find or create images, including tables, figures, illustrations or photographs, and you will document all of your sources.
Find more easy contacts at our Quick Start Guide
IMAGES
COMMENTS
INTRODUCTION. Dementia is a common public health problem. 1 Worldwide, approximately 47 million people have dementia and this number is expected to increase to 131 million by 2050. 1 Reductions in age-adjusted incidence of dementia have occurred in the United States (US) and other developed countries over the last 20 years, perhaps associated with increasing formal educational attainment.
The number of older people, including those living with dementia, is rising, as younger age mortality declines. However, the age-specific incidence of dementia has fallen in many countries, probably because of improvements in education, nutrition, health care, and lifestyle changes. Overall, a growing body of evidence supports the nine potentially modifiable risk factors for dementia modelled ...
According to recent research, increasing physical activity levels has been found to have a preventive effect on approximately 3% of all dementia cases [67, 68]. Additionally, engaging in physical activity and exercise has been shown to improve overall cognitive function in individuals with dementia [69].
In one hospital inpatients' survey nearly 35% of those older than 80 years experienced delirium; those with prior cognitive impairment had 15 times the risk of developing delirium than those without (OR 15·3, 95% CI 5·2-45·4). 282 People with delirium without known dementia are more likely to be diagnosed with dementia in the future than ...
The 2024 update of the Lancet Commission on dementia provides new hopeful evidence about dementia prevention, intervention, and care. As people live longer, the number of people who live with dementia continues to rise, even as the age-specific incidence decreases in high-income countries, emphasising the need to identify and implement prevention approaches. We have summarised the new research ...
Importance: Dementia affects 10% of those 65 years or older and 35% of those 90 years or older, often with profound cognitive, behavioral, and functional consequences. As the baby boomers and subsequent generations age, effective preventive and treatment strategies will assume increasing importance. Observations: Preventive measures are aimed ...
Importance: Worldwide, 47 million people live with dementia and, by 2050, the number is expected to increase to 131 million. Observations: Dementia is an acquired loss of cognition in multiple cognitive domains sufficiently severe to affect social or occupational function. In the United States, Alzheimer disease, one cause of dementia, affects 5.8 million people.
Dementia is a common public health problem. 1 Worldwide, approximately 47 million people have dementia, and this number is expected to increase to 131 million by 2050. 1 Reductions in age-adjusted incidence of dementia have occurred in the United States and other developed countries over the last 20 years, perhaps associated with increasing formal educational attainment.
Currently, with no known cure for dementia or dementia-related conditions, including Alzheimer's disease and young onset dementia, the participants emphasised the utmost need for research focusing on the development and trial of treatment and programs that would cure or at least slow cognitive decline. 19,23 Patel et al 25 and Armstrong et al ...
A qualitative study of the benefits and challenges of different models of extra care housing for residents living with dementia. Rebecca Oatley. Teresa Atkinson. Preview abstract. Open Access Research article First published May 3, 2024 pp. 981-1000. xml PDF / EPUB.
The growing prevalence of dementia emphasizes the need for continued research, collaboration and investment in this field to improve the quality of life of those living with dementia and their ...
Dementia articles from across Nature Portfolio. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury ...
The category of dementia, as described in this Article, is referred to under the name Alzheimer's disease and other dementias in GBD 2019. General GBD methods can be found in the GBD 2019 summary papers and in the appendix (pp 10-11). 12,21,22 The overall GBD protocol and data visualisation tools can be found online.
Abstract. An estimated 50 million people worldwide have dementia, mostly due to Alzheimer's disease. The inexorable progression of Alzheimer's disease exerts a huge toll on patients, families ...
This Narrative Review summarizes current evidence and explores emerging science on the prevention and treatment of dementia to inform clinical [Skip to Navigation] Our website uses cookies to enhance your experience. ... 5 Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan. JAMA Intern Med. 2024;184(5 ...
Dementia is a common term for a chronic functional decline caused by disease or damage in the brain, where Alzheimer's disease is the most common [1, 2].During progression of this decline the need for help from others are unavoidable and the focus moves from maintenance of daily functioning and activities in early phase towards comfort and well-being in late stage [].
Here the authors present a deep learning framework for dementia diagnosis, which can identify persons with normal cognition, mild cognitive impairment, Alzheimer's disease, and dementia due to ...
1. Introduction. Alzheimer's disease (AD) (named after the German psychiatric Alois Alzheimer) is the most common type of dementia and can be defined as a slowly progressive neurodegenerative disease characterized by neuritic plaques and neurofibrillary tangles (Figure 1) as a result of amyloid-beta peptide's (Aβ) accumulation in the most affected area of the brain, the medial temporal ...
This paper aims to bridge this divide by offering a tripartite exploration of dementia research through three distinct, yet interconnected, lenses of a person living with the disease, their dedicated carer, and a researcher actively engaged in dementia research. This collaborative endeavour highlights the need to move beyond the traditional ...
The recommendations were crafted by an expert panel and refined by a working group of dementia researchers and clinicians. The article contains 40 recommendations for this trial type, including guidelines for safety, dispensing, outcome assessment, and data collection.
In 2022, multiple research milestones have occurred in the field of dementia. Therapeutics went through a fundamental transition, with amyloid-β (Aβ) targeted drugs gradually moving from clinical trials into real-world application. Encouraging findings on biomarkers and risk factors also marked the ongoing shift towards precise diagnosis and early prevention. We believe that this progress ...
Mild cognitive impairment and dementia: strategies for prevention. Evidence supports the existence of prodromal stages of dementia, including preclinical disease and the early clinical stage of MCI. 8,9 The hallmark of MCI is the presence of cognitive deficits beyond what is expected for age but not severe enough to cause disruption of daily life. 10,11 MCI represents a common prodrome of ...
People living with dementia and their carers often experience difficulties in effectively managing medications and have indicated they . ... Mouna J Sawan is supported by the Dementia Centre for Research Collaboration Fellowship. Amanda J Cross is supported by a National Health and Medical Research Council Emerging Leadership 1 grant (APP2009633).
On 4 October 2022, the WHO released a dementia research blueprint to support implementation of the Global action plan on the public health response to dementia in 2017-2025, representing a first ...
Who is affected. Alzheimer's disease is the most common form of dementia. 1. A recent study suggests that the number of people with clinical Alzheimer's disease is expected to increase from about 6.9 million people in 2024 to about 14 million people in 2060. 1 The largest increases are expected among people from racial/ethnic minority groups. 1 Cases among Hispanic adults are expected to ...
Two new papers show how TRIM21 techniques can remove tau tangles inside of mouse neurons and improve mobility in a mouse ... now at the UK Dementia Research Institute at the University of ...
Payne alerted BioSystems, which rejected the paper in March. But in July, Payne found a reworked version of his and Boekweg's paper had been published in the journal Proteomics under the names of five other researchers. This version was more sinister; it was Payne's and Boekweg's paper, but it used the third person.
Dementia is a leading public health crisis that is projected to affect 152.8 million individuals by 2050, over half of whom will be living in the Western Pacific region. To determine the challenges and opportunities for capacity building in the region, this scoping review searched databases. Our findings reveal national and ethnoracial differences in the prevalence, literacy and genetic risk ...
Data Collection and Strings Definition. PsycINFO, PubMed, and CINAHL were the online databases where we sought peer-reviewed papers published from January 2010 to October 2020 (Table 1).The research query combined keywords from three different research strings (A, B, C) through the Boolean operators "AND" and "OR" (Table 2).String A included the studies that were related to technology ...
The research you do for your white paper will require that you identify a specific problem, seek popular culture sources to help define the problem, its history, its significance and impact for people affected by it. You will then delve into academic and grey literature to learn about the way scholars and others with professional expertise ...